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Abstract
Background: Delirium is associated with devastating outcomes, cognitive loss,
decreased function and an increase risk of mortality which affects patients and places a
heavy burden on family and the healthcare system. The purpose of this study was to
describe the relationship between select demographics, clinical characteristics, CHARTDEL-derived delirium diagnosis and ICD-10 coded discharge delirium diagnoses among
Long Term Care (LTC) rehabilitation residents.
Method: A retrospective correlational design from174 LTC rehabilitation residents age
65 years or older using EMR and hard copy charts. The setting was a Southern California
community hospital-based 100-bed LTC. Abstracted data included demographic
characteristics (age, gender, race), principal admitting diagnosis, admission source,
discharge disposition, medication management (polypharmacy, psychotropic medications
duration), presence of dementia, CHART-DEL-derived delirium diagnoses documented
delirium symptoms and International Classification of Disease, 10th revision (ICD 10)
coded delirium, LOS, Charlson score (comorbidities). Statistical methodology included:
descriptive statistics for demographic and other variable data. Chi square for relationship
between delirium and the independent variables. ANOVA described the difference
between the variables. Multiple logistic regression determined the odds of having a
delirium diagnosis (by either approach with separate models) based upon gender, race,
principle admitting diagnosis, polypharmacy, dementia, age, LOS, Charlson score
(comorbidities), and psychotropic medications duration.
Results: Majority residents were female, white, average age 80.6, 99.4% acute care
admissions, and 96.6% had polypharmacy. Psychotropic duration mean was 9.5 days,

LOS 14.7 days, and 64.9% discharged home with home health. More delirium identified
with CHART-DEL-derived delirium diagnoses (24.9%) compared to ICD-10 code
diagnosis (5.2%). The Charlson score (comorbidity) was related to delirium in both
models (CHART-DEL-derived p = .044; ICD-10 code p = .002), while LOS additionally
explained variance, but only in CHART-DEL-derived delirium model.
Conclusions: The daily use of a delirium-screening instrument by the healthcare team
could assist with delirium identification sooner and implement appropriate interventions.
This then could decrease negative outcomes of delirium, improve satisfaction among
family and staff and increase resident quality of care and safety.
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Chapter One
Introduction
Delirium is a rapidly growing geriatric syndrome with devastating negative
outcomes reflected in clinical and functional decline, cognitive impairment, and increased
morbidity and mortality (Bellelli, Mazzola, & Morandi, 2015; Inouye, Westendorp, &
Saczynski, 2014; Kiely et al., 2009; Voyer, Richard, Doucet, Cyr, & Carmichael, 2011).
Delirium can increase the risk of cognitive loss, long term care placement, family
burden/stress, reduce function and independence, impact the quality of life for the older
adult, and increase the use of healthcare resources resulting in costlier healthcare
(Akunne, Murthy, & Young, 2012; Bellelli et al., 2007; Fick et al., 2015; Huson, Stolee,
Pearce, Bradfield, & Heckman, 2016; McAvay et al., 2006; McCusker et al., 2011b;
Popp, 2013; Steis & Fick, 2012; Yoo, Nakagawa, & Kim, 2013). Delirium, both
incidence and prevalence, have been extensively studied in the acute care setting noting
that delirium can persist for weeks and months (Marcantonio et al., 2003). Other studies
indicated delirium is no longer just an acute care concern; 20% to 70% of 12.5 million
elderly hospitalized adults experience delirium and there was a 50% increase in patients
with delirium discharged to post-acute care (PAC) in 2010 versus 1996. In addition, one
fifth of hospitalized patients are admitted to skilled nursing facilities with delirium due to
a shortened hospital length of stay (LOS) trend, leading to a critical need to address
delirium in the post-acute care setting. Reports of delirium prevalence in the older adult
can range from 22% to 89% (Élie et al., 2000; Fick, Agostini, & Inouye, 2002;
Lemiengre et al., 2006) and 3% to 70% in long-term care (LTC) (McCusker et al.,
2011a). Some critical pieces of the delirium puzzle are that delirium is not a normal
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process of aging; 30–40% of cases are preventable and the etiology of the onset of
delirium is multifactorial (Inouye et al., 1999; Marcantonio, Flacker, Wright, & Resnick,
2001). It becomes essential to assist clinicians to understand and recognize the predictors
of delirium in LTC so staff can prevent the occurrence of delirium. When it does occur,
the staff can better manage the occurrence so the risk and severity of the negative
outcomes associated with delirium may be minimized (Inouye et al., 2014).
Risk factors have been thoroughly explored in the acute care setting; however,
there is a paucity of studies investigating predictors of delirium in LTC and even fewer in
the LTC rehabilitation resident. With better awareness of what triggers delirium, the
clinician will be better able to prevent, identify, and manage delirium.
Background
Delirium has been studied for centuries and contributed to the current
understanding of the syndrome. Celus was the first author to label delirium when
describing mental disorders associated with fever or head trauma and the first to report a
non-febrile delirium (Adamis, Treloar, Martin, & Macdonald, 2007). In the 19th century,
a definition of delirium, “clouding of consciousness” (Adamis et al., 2007, p. 466) and
confusion were introduced as part of delirium and symptoms were included in the
definition. The 20th century was instrumental in the identification of the various
symptoms of delirium (psychosis, hallucinations, stupor) including the development of
the Diagnostic and Statistical Manual of Mental Disorders (DSM) and International
Classification of Diseases (ICD) (Adamis et al., 2007). The DSM was formulated to
address the need to standardize the characterization and diagnosing of mental disorders
(Kawa & Giordano, 2012). The ICD was developed by the World Health Organization to
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improve classification of mental disorders internationally (ICD-10 Classification). The
fact that delirium has been studied for centuries supports the concept that delirium is
complex and continues to evolve as more understanding is gained.
Consequences of Delirium
Delirium is strongly associated with many iatrogenic adverse outcomes and often
the older adult hospitalized patient develops an accelerated physical and cognitive decline
(Fong, Jones, et al., 2009; Khan et al., 2012). Delirium is characterized by key
neuropsychiatric symptoms such as acute altered mental status, inattention, disorganized
thinking, and disturbICD-10
ances in consciousness. A fluctuating course for patients and residents has been
observed in all healthcare settings, particularly in LTC (Fong, Tulebaev, & Inouye, 2009;
Khan et al., 2012). The hospital-acquired complications may include falls, urinary tract
infection, an increased LOS, and a decreased ability to manage activities of daily living
resulting in high admission rate to a PAC facility (Khan et al., 2012). Patients with
delirium requiring an emergency department visit post-discharge represent 8–17% of all
seniors and 40% of nursing home residents.
Mortality is also linked to delirium with an estimated 11% increased risk of dying
in residents with every 48 hours with delirium (Young et al., 2015). The association of
delirium and mortality is seen across all settings including acute care (intensive care unit,
general medical units, geriatric, stroke, and dementia units), emergency departments, and
nursing homes (Inouye et al., 2014). The incidence of delirium is reported to be 29% to
64% in general medical and geriatric units, 8% to 17% in older adults in the emergency
department (ED), and up to 70% in LTC residents (Inouye et al., 2014; Moyo, Huang,
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Simoni-Wastila, & Harrington, 2016). The occurrence of delirium in the intensive care
unit has a 2 to 4 times increased risk of death, a 1.5 times increased risk of death in the
medical or geriatric units one year after discharge from an acute care hospitalization, and
a 70% increased risk of death 6 months following an ED visit (Inouye et al., 2014).
Patients who develop delirium may experience a longer-term impact. The
symptoms of delirium have been reported as far out as 12 months with only a gradual
recovery (Siddiqi, House, & Holmes, 2006). Another long-term impact is the onset of
dementia occurring annually in 18% of patients who develop delirium versus 6% without
delirium (Rockwood et al., 1999). Patients with a hip fracture requiring surgical
intervention have a greater risk of developing delirium, 16–62%, with recovery ranging
from a couple days to one year (Deiner & Silverstein, 2009). The post-operative delirious
patient can experience cognitive impairment as far out as one year and the physical
functional status of both the surgical and non-surgical delirious patient can be
compromised for 30 days or more (Inouye, Westendorp, et al., 2014).
Delirium has been studied for causative factors, treatment, and prevention to
reduce the incidence of delirium. Delirium, a preventable condition and not a normal part
of the aging process, is associated with health status and drug use (Alagiakrishnan, 2004;
Moyo et al., 2016; Potter & George, 2006). In a seminal study, Inouye, Schlesinger, and
Lydon (1999) reported that 50% of delirium cases could be prevented. They also
reported a 25% reduction in delirium with the implementation of key preventive
measures. According to this study, preventative measures to reduce the incidence of poor
patient outcomes are associated with an increase demand on healthcare resources and cost
(Inouye et al., 1999). As a result of the outcomes and treatment for delirium, which
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include outpatient care, the financial impact to the healthcare system ranges between $38
billion and $152 billion annually (Leslie, Marcantonio, Zhang, Leo-Summers, & Inouye,
2008). The cost attributed to delirium ranges from $16,303 to $64,421 per patient with all
settings considered, which includes LTC (Leslie & Inouye, 2011). In 2011, the financial
impact of delirium on healthcare in the United States was $165 billion and over $182
billion in 18 European countries (Inouye, Westendorp, et al., 2014).
LTC Resident Adults
By 2030, 20% of the U. S. population will be 65 years of age or older and 30
million people will have a healthcare or social care need requiring LTC (Arinzon,
Peisakh, Schrire, & Berner, 2011). The two most common cognitive disorders in the
LTC resident are dementia and delirium (Arinzon, Peisakh, Schrire, & Berner, 2011).
The prevalence of delirium in the LTC resident population ranges between 9.6% 89%
(Arinzon et al., 2011). Kiely and colleagues (2003) found 16% of patients suffered from
delirium upon admission to PAC facilities. In acutely ill residents of a nursing home,
Boockvar, Signor, Ramaswamy, and Hung (2013) identified a 17.7% incidence of
delirium. These residents developed delirium, on average, on the third day following the
onset of an acute illness (Boockvar et al., 2013).
Older adults who reside in LTC are unable to maintain independent living and
have both healthcare (physical and/or mental) and social care needs making them an
extremely frail subgroup in the population of older adults (Crocker et al., 2013). Salem et
al. (2014) defined frailty as “a state that affects an individual who experiences an
accumulation of deficits in physical, psychological, and social domains, leading to
adverse outcomes such as disability and mortality” (page 1). Residents who developed
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delirium faced the risk of poor outcomes that include a 23% increased risk of falling and
two-fold risk of being re-hospitalized. Length of stay (LOS) was more likely to be greater
than 30 days and there was greater than six-month mortality as compared to those without
delirium (Marcantonio et al., 2005).
Delirium has become a patient safety and cost focus. A driving factor for
instituting preventative measures is that 30–40% of delirium cases can be prevented
(Inouye, Westendorp, et al., 2014). Delirium is now an indicator for healthcare quality
for this population in the Value Base Purchasing Program (VBP) for nursing homes. The
political climate in healthcare has moved from pay for simply reporting the volume of
healthcare outcomes to currently receiving reimbursement based on achievement and
performance (Centers for Medicare and Medicaid Services, 2015). The FY 2019 Skilled
Nursing Facility (SNF) Prospective Payment System (PPS) effective July 31, 2018, was
part of the Protecting Access to Medicare Act of 2014 (PAMA) public law no. 113-93
and authorized the new nursing home VBP to begin in FY 2019 (Medicare Program,
2018). The outcome measure under this law is 30-day all-cause readmissions (Centers
for Medicare and Medicaid Services, 2015). The Improving Medicare Post-Acute Care
Transformation Act (IMPACT) 2014 focused on improving quality in SNF and LTC
facilities focusing on three domains of improvement: 1) skin integrity and changes in skin
integrity, 2) incidence of major falls, and 3) functional status, cognitive function, and
changes in function and cognitive function. The measurement for the three domains
includes new or worsened pressure ulcers, falls with major injury, and assessment and
care planning for functional status. The quality measures will also be posted on the
public reporting venues (Protecting Access to Medicare Act, 2014).
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VBP has not only a quality improvement focus but also represents a cost impact
to the LTC setting. The Congressional Budget Office anticipates a $2 billion savings to
Medicare over the next 10 years. Beginning in 2018, CMS began withholding 2% of
Medicare reimbursements to SNFs and would pay some or all of those funds based on the
facility’s performance in meeting the new requirement. (Protecting Access to Medicare
Act, 2014).
Research Questions
Research questions for this study were:
1. What is the relationship between CHART-DEL-derived delirium diagnosis and
documented ICD-10 coded discharge delirium diagnosis in LTC rehabilitation
residents?
2. What is the relationship between delirium (CHART DEL-derived and ICD-10) and
variables of gender, race, principle admitting diagnosis, polypharmacy, dementia,
age, LOS, Charlson score (comorbidities), and psychotropic medications duration in
LTC rehabilitation residents?
Purpose
The purpose of this study was twofold: 1) to describe the relationship between
CHART-DEL-derived delirium diagnosis and the ICD-10 coded discharge delirium
diagnosis, and 2) to describe the relationship between delirium (CHART DEL-derived
and ICD-10) and the variables of gender, race, principle admitting diagnosis,
polypharmacy, dementia, age, LOS, Charlson score (comorbidities), and psychotropic
medications duration in the LTC rehabilitation residents.
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Aims
The aims of this study were to:
1. Describe resident demographic characteristics of gender, race, principal
admitting diagnosis, admit source, discharge disposition, polypharmacy, dementia,
CHART-DEL-derived delirium diagnoses, ICD-10 coded discharge delirium diagnosis,
age, LOS, Charlson score (comorbidities), and psychotropic medications duration.
2a. Describe the relationship between CHART-DEL-derived diagnoses and the
variables of gender, race, principle admitting diagnosis, polypharmacy, dementia, age,
LOS, Charlson score (comorbidities), and psychotropic medications duration.
2b. Describe the relationship between ICD-10 delirium and the variables of
gender, race, principle admitting diagnosis, polypharmacy, dementia, age, LOS, Charlson
score (comorbidities), and psychotropic medications duration.
3a. Determine the odds of having a diagnosis of CHART-DEL-derived delirium
diagnosis based upon gender, race, principle admitting diagnosis, polypharmacy,
dementia, age, LOS, Charlson score (comorbidities), and psychotropic medications
duration.
3b. Determine odds of having an ICD-10-derived delirium diagnosis based upon
gender, race, principle admitting diagnosis, polypharmacy, dementia, age, LOS, Charlson
score (comorbidities), and psychotropic medications duration.
Study Theoretical Underpinnings
Homeostenosis
Although well described, delirium is complex, difficult to identify, and not fully
understood. The homeostenosis concept is used to explore the occurrence of delirium in
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the older adult and to obtain a better understanding of delirium. Homeostenosis suggests
the older adult may have stable and functional independent health, but the aging process
makes the older adult more vulnerable to decompensating in response to physiological
disturbances such as stressors and illnesses that may not have the same impact in the
health of the younger adult (Maldonado, 2013). An outcome of the aging process is that
older adults succumb to illness more frequently than younger adults due to the poor
physiological reserve (Maldonado, 2013). The physiological changes affected by the
aging process include brain dysfunction due to a decrease in blood flow, a decline in
stress-regulating neurotransmitters, neuron loss (35 % from locus coeruleus and sustantia
nigra), vascular changes, and changes in the intracellular signal transductions systems
(Maldonado, 2013). With this physiologic vulnerability, reserved capacity is depleted in
the older adult. This may explain why the older adult brain decompensates with an
exposure to a medication or illness but this same noxious stimuli does not have the same
effect in the younger individual (Maldonado, 2013; Flacker & Lipsitz, 1999).
Multifactorial Model of Delirium in Older Persons
Unlike the younger adult, Inouye and Charpentier (1996) identified the older adult
patient with vulnerable factors (predisposing factors) and exposed to noxious stimulus
(precipitating factors) may be more vulnerable to the development of delirium. Most
recently, as a concept, delirium was defined as acute fluctuating attention and cognitive
changes in mental status (Inouye et al., 2014).
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Figure 1. Multifactorial Model of Delirium in Older Persons

Figure 1 graphically displays a model that was used to develop the conceptual
framework for this study. “The onset of delirium involves a complex interaction between
the patient’s baseline vulnerability (predisposing factors) present on admission, and
precipitating factors or noxious insults occurring during hospitalization” (Inouye,
Westendorp, et al., 2014, p. 20).
The onset of delirium is mostly associated with multiple factors and rarely due to
a single factor (Inouye, Westendorp, et al., 2014). Inouye and Charpentier (1996) found
that reported studies evaluated risk factors but did not separate the baseline vulnerability
and precipitating factors, thereby preventing the researchers from understanding the
effects each factor contributed to the onset of delirium. They further hypothesized that
delirium was a multifactorial geriatric syndrome. This highly utilized Multifactorial
Model of Delirium in Older Persons has been tested and validated subsequent to their
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first report. The model indicates the higher the baseline vulnerabilities upon admission,
the least amount of precipitating factors (insults) will be needed to trigger the onset of
delirium. The opposite is also true. If the patient has a low vulnerability on admission
then many precipitating factors during hospitalization would be needed to trigger the
onset of delirium (Inouye & Charpentier, 1996).
In their binomial regression model, Inouye and Charpentier (1996) included a
baseline risk score, five precipitating factors, and exposure period (by 9th hospitalized
day) revealing a significant independence between baseline and precipitating factors.
This supported the researchers’ hypothesis that there was a resistance to the onset of
delirium in low-risk baseline patients and high-risk baseline patients were susceptible to
the onset of delirium with any precipitating factors (Inouye & Charpentier, 1996).
The predisposing factors/vulnerability have been well studied in both acute care
and LTC. The predisposing factors/vulnerability included functional impairment,
dehydration, fever, hearing and visual impairment, behavioral disturbances, depression,
comorbidity, pain, dehydration, malnutrition, hearing; however, advanced age and
dementia were the two most significant factors in this group (Davis et al., 2012; Voyer,
Richard, Doucet, & Carmichael, 2009b). The variables of age, comorbidities, and
dementia were the predisposing/vulnerable factors evaluated in this study.
Precipitating factors identified in the previous studies included physical restraints,
malnutrition, number of medications (greater than three), urinary catheter, and iatrogenic
adverse event. The percentage of psychotropic medications found in the greater than
three medications factor were at least 1 (70%), 1 (30%), 2 (20%), and 3 (13%) (Inouye &
Charpentier, 1996). In this study, the precipitating factors included polypharmacy and
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duration of psychotropic medications. See Figure 2 for the model created as the
framework for this research.

Figure 2. Study Conceptual Framework

Summary
Delirium is a devastating syndrome especially among the older adult population.
As more functionally impaired older adults survive acute illnesses, there is an increase in
the number of residents requiring admission to LTC for both short- and long-term care.
With admission to LTC, residents are at an increased risk of poor outcomes. Most studies
have addressed delirium in acute care, some have addressed delirium in the LTC setting,
but few have addressed those admitted to LTC for rehabilitation and the relationship
between CHART-DEL-derived delirium symptoms and ICD-10 coded delirium diagnosis
delirium along with the variables of gender, race, principle admitting diagnosis,
polypharmacy, dementia, age, LOS, Charlson score (comorbidities), and psychotropic
medications duration. This study is unique as it compares CHART-DEL-derived delirium
diagnoses documented delirium symptoms and ICD-10 in the LTC rehabilitation
population.
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Chapter Two
Review of the Literature
This chapter will provide a review of published articles related to delirium. The
researcher used the following databases and websites: CINAHL, PubMed, Ovid,
Cochrane, Google, Google Scholar, CMS, HELP (Hospital Elder Life Program), and
NIH. Primary articles from a reference list of systematic reviews and meta-analyses were
also included in the search. The search timeframe was over the most recent 10 years.
However, an exception was made regarding related models that went back to 1996 when
the original model used to underpin this study was developed. The articles included a
critical review of the various aspects of delirium and were organized into the following
sections: overview of delirium, definition and symptomology, delirium subtypes,
pathophysiology, risk factors, comorbidities, long term care, screening, length of stay,
intensive care unit, post-acute care, treatment/intervention, nonpharmacological
management, pharmacological interventions, medication management, psychotropic
medications, polypharmacy, and post-acute care/long term care rehabilitation.
Overview of Delirium
As the population ages, the issue of delirium development among older adult
patients requires urgent attention since it can increase mortality by more than 25%,
accelerate the onset of dementia, decrease independence, experience adverse iatrogenic
event(s), and contribute to a longer, costlier healthcare experience (Huson et al., 2016;
Marcantonio et al., 2005). Delirium, a common occurring and devastating syndrome
frequently underdiagnosed, is strongly associated with many iatrogenic adverse outcomes
and often the older adult resident develops an accelerated physical and cognitive decline
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(Khan et al., 2012; Fong, Jones et al., 2009). Marcantonio et al. (2005) conducted an
observational cohort study in an LTC facility with a PAC unit. Only residents admitted
to the PAC unit were included in the study. The outcomes described were delirium,
subsyndromal, and no delirium. The study revealed PAC residents with delirium versus
PAC residents without delirium were associated with one or more complications (73%
versus 41%), re-hospitalized (30% versus 13%), placed in the community upon discharge
(30% versus 73%) and all complications were significantly different between the two
groups (p<.01) with delirium having more complications. A 6-month mortality was
another important measured outcome that compared the resident with delirium versus no
delirium, 25% and 5.7% respectively (Marcantonio et al., 2005).
The occurrence rate of delirium in the hospital and in the intensive care unit (ICU)
ranged from 11% to 42% and 16% to 89% respectively (Abelha, Veiga, Norton, Santos,
& Gaudreau, 2013; Siddiqi et al., 2006). Not only are there serious health and quality of
life consequences due to delirium but there is also a significant cost ranging from $143 to
$152 billion annually estimated based on U. S. dollars from 2005 (Fick et al., 2015).
This represents twice the cost of care for older adult patients with delirium (Fick et al.,
2015; Lesli, Marcantonio, Zhang, Leo-Summers, & Inouye, 2008; Steis & Fick, 2012).
Definition and Symptomology
Delirium is described as an acute, cognitive impairment evidenced by the key
features of confusion and inattention that fluctuate throughout the day. The confusion
may display in the form of disorientation or memory loss. The inattention symptom
includes lack of focus, disorganized thinking, and altered level of consciousness or
inability to shift attention. Other symptoms may be irritability, psychomotor and
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visuospatial problems, hallucinations, delusions and sleep-wake cycle issues (Kukreja,
Günther, & Popp, 2015). The onset of delirium is fairly rapid, occurring within a few
hours to days. Diagnosis does not require all of these symptoms to present at the same
time (Cavallazzi, Saad, & Marik, 2012). The fluctuation and similarity with symptoms
attributed to dementia and depression contribute to the difficulty in detecting delirium
(Inouye et al., 1999). Of note, delirium does decrease daily living activities and enhance
symptoms of dementia (Hasegawa et al., 2013; Khurana, Gambhir, & Kishore, 2011).
The two delirium diagnostic instruments are the American Psychiatric
Association (APA) Diagnostic and Statistical Manual, current version (fifth edition),
(DSM-5) and the International Statistical Classification of Diseases version 10 (ICD-10)
(APA, 2013; ICD-10, 2011). The DSM-5 (2013) and ICD-10 (2011) define delirium for
diagnostic reference but are not easily adoptable for the bedside use (Shi, Warren,
Saposnik, & MacDermid, 2013). Delirium screening instruments have been developed to
be easily applied at the bedside and have utilized the DSM-5 and ICD-10 as the reference
gold standards when validating the instruments. The DSM-5 defines delirium as follows:
(a). Disturbance in attention (i.e., reduced ability to direct, focus, sustain, and shift
attention) and awareness (reduced orientation to the environment).
(b). The disturbance develops over a short period of time (usually hours to a few
days), represents a change from baseline attention and awareness, and tends to
fluctuate in severity during the course of a day.
(c). An additional disturbance in cognition (e.g., memory deficit, disorientation,
language, visuospatial ability, or perception).
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(d). The disturbances in criteria A and C are not explained by another preexisting,
established, or evolving neurocognitive disorder and do not occur in the
context of a severely reduced level of arousal, such as coma.
(e). There is evidence from the history, physical examination, or laboratory
findings that the disturbance is a direct physiologic consequence of another
medical condition, substance intoxication or withdrawal (i.e., because of a
drug of abuse or to a medication), or exposure to a toxin or is because of
multiple etiologies (p. 596).
The ICD-10 is the diagnostic instrument utilized by healthcare coders to
determine diagnosis(s) when patients are discharged. The ICD-10 (2011) defined
delirium as:
(a) impairment of consciousness and attention (on a continuum from clouding to
coma; reduced ability to direct, focus, sustain, and shift attention);
(b) global disturbance of cognition (perceptual distortions, illusions and
hallucinations - most often visual; impairment of abstract thinking and
comprehension, with or without transient delusions, but typically with some
degree of incoherence; impairment of immediate recall and of recent memory
but with relatively intact remote memory; disorientation for time as well as, in
more severe cases, for place and person);
(c) psychomotor disturbances (hypo or hyperactivity and unpredictable shifts
from one to the other; increased reaction time; increased or decreased flow of
speech; enhanced startle reaction);
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(d) disturbance of the sleep-wake cycle (insomnia or, in severe cases, total sleep
loss or reversal of the sleep-wake cycle; daytime drowsiness; nocturnal
worsening of symptoms; disturbing dreams or nightmares, which may
continue as hallucinations after awakening);
(e) emotional disturbances, e.g. depression, anxiety or fear, irritability, euphoria,
apathy, or wondering perplexity (p. 56).
Delirium Subtypes
Persons can exhibit delirium in a wide variety of ways. There are 3 subtype
classifications of delirium. The most recognized and easiest to diagnose is the
hyperactive delirium. The hyperactive case presents itself in agitation, irritability, lack of
concentration, and perseveration (Cavallazzi et al., 2012). Hypoactive delirium, the most
common and often misdiagnosed, is present when the patient is subdued, lethargic,
comatose, with absence of or slowed speech and hypokinesia. The third subtype is a mix
of hyperactive and hypoactive delirium. Khurana and colleagues (2011) reported the
prevalence of hypoactive, hyperactive, and mixed delirium as 65%, 25%, and 10%,
respectively.
In the acute care setting, the association between delirium psychomotor activity
subtypes and mortality has been well-described but none have been reported in PAC/LTC
rehabilitation. Kiely, Jones, Bergmann, and Marcantonio, (2007) recognized the need to
assess the association between psychomotor activity delirium subtypes and 1-year
mortality in PAC/LTC rehabilitation facilities and compare the results with previous
studies. The prospective study was part of a randomized controlled trial (RCT) of a
Delirium Abatement Program (DAP) from October 2000 to June 2003 and included eight
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Boston-area skilled nursing facilities with a PAC unit specifically for rehabilitation and
cognitive recovery. The results of the delirium subtypes revealed 46.4% were hypoactive,
31.3% normal, 12% mixed, and 10.3% hyperactive. The 1-year mortality survival
trajectory was in the hypoactive group and significant (log rank 10.9; p = .01). The
hazard ratio (HR) compares the risk of dying within the 1-year follow up timeframe from
abnormal psychomotor activity to normal psychomotor activity. The resident HR risk of
dying compared to normal activity had hypoactive psychomotor activity with a
significant and greatest risk of dying HR 1.60%, CI 1.11-2.37; p <. 01; mixed HR 1.26,
CI 0.73-2.14, P <. 40, and hyperactive HR 1.23, CI 0.70-2.18, p <. 47 not significant and
had the lowest risk.
The researchers’ conclusion that the hypoactive delirium subtype resident was
significantly at the greatest risk of dying within 1 year is important, as the hypoactive
subtype is the most common type in LTC/PAC and it is the subtype most often under
recognized. The study was conducted in a metropolitan area, which may make it difficult
to generalize the results to previous studies conducted in rural settings, rehabilitation
hospitals, or the community setting. The strength and limitations remain the same as with
the previous studies within the DAP population.
Pathophysiology
The mechanism that triggers delirium is not completely understood; however,
there are studies that identify neurotransmitter involvement. What is known is that
delirium does accelerate the cerebral disturbance the patient may already have. The
medical conditions contributing to delirium include inflammation, cerebral
hypoperfusion, oxidative stress, mitochondrial dysfunction, and hypothalamic and
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pituitary adrenal axis hyperresponsiveness (Kukreja et al., 2015). It is suggested the
neurotransmitter system interaction with cholinergic, acetylcholine, serotonergic,
dopamine, and noradrenaline glutamate activity contributed to the onset of delirium
(Cavallazzi et al., 2012; Kukreja et al., 2015).
Acute illness, trauma, surgery, and drugs are known precipitating factors to the
onset of delirium but what is not well understood is the molecular means by which these
factors contribute to delirium (MacLullich, Ferguson, Miller, de Rooij, & Cunningham,
2008). The predisposing factors for delirium, such as ageing and central nervous system
disease have an associated impact on the stress and behavior responses (MacLullich et
al., 2008).
MacLullich et al. (2008) categorized the etiological factors into two groups: direct
brain insults and aberrant stress. Direct brain insult includes factors that acutely impact
the brain function and disrupts the neuron network (Inouye, Westendorp, et al., 2014;
MacLullich et al., 2008). This brain dysfunction can be attributed to multiple factors
including metabolic abnormalities, trauma, hemorrhage, or drugs that directly affect
neurotransmission (MacLullich et al., 2008). Multiple areas of the brain can be affected
by hypoxemia or systemic hypoglycemia. Local impact may be attributed by thrombosis,
hemorrhage, or vasospasm by occluding key cholinergic pathways and basal ganglia. A
common outcome associated with septic shock is delirium and may be due to impaired
cerebral perfusion and blood brain permeability. Central nervous system diseases such as
meningitis or encephalitis may be due to metabolic disturbance or parenchyma damage
that impacts acetylcholine neurotransmitters (MacLullich et al., 2008). Pharmacological
brain insult is described as affecting the neurotransmission when the dopaminergic
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system is overly active and cholinergic system is underactive (MacLullich et al., 2008).
Inouye et al. (2014) described contributors to delirium as mechanisms and biological
factors (likely a direct impact on neurotransmission and/or cellular metabolism). Major
mechanisms included “neurotransmitters, inflammation, physiological stressors,
metabolic derangements, electrolyte disorders, and genetic factors” (Inouye, Westendorp,
et al., 2014 p. 5). The biological factors included drugs, hypercortisolism, electrolyte
disturbances, hypoxia, or impaired glucose oxidation (Inouye, Westendorp, et al., 2014).
Aberrant stress is the second category that contributes to the acute onset of
delirium. Pathology, aging, neurodegeneration, negative systemic factors (stress,
infection, injury, and surgery) impaired stress response, and heightened inflammatory all
may interact and contribute to the onset of delirium (MacLullich et al., 2008). During
the stimulation of the immune system, changed behavior may be due to the central
nervous system synthesis of pro-inflammatory mediators (cytokines and prostaglandins)
(Inouye et al., 2014; MacLullich et al., 2008). The systemic inflammatory routes could
be the pathogen directly interacting with neurons, stimulating endothelial brain cells to
secrete prostaglandins in the brain parenchyma or vagal nerve stimulating the brain by
neural pathway (Inouye, Westendorp, et al., 2014; MacLullich et al., 2008). The blood
brain barrier is another critical player in this process. The impact that age, diabetes,
Alzheimer’s, vascular dementia have on the structure and function of the blood brain
barrier results in the inappropriate strength of the inflammatory signals causing a negative
impact. The interaction of the neurodegenerative disease already inflamed (microglia
activation), the systemic inflammatory cytokines and the degree of central nervous
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system response is likely to contribute to a more severe response (Inouye, Westendorp, et
al., 2014; MacLullich et al., 2008).
Risk Factors
Delirium is complex, preventable, and rarely a single factor; rather, it is
commonly multifactorial (Inouye, Westendorp, et al., 2014). Each resident has a
different level of susceptibility to the onset of delirium, which can be dependent on
various factors (Young, Murthy, Westby, Akunne, & O’Mahony, 2010). Risk factors are
categorized into predisposing or precipitating factors. Predisposing risk factors are
resident baseline vulnerability factors and precipitating factors are potentially modifiable
insults or environmental factors that contribute to the onset of delirium (Davis et al.,
2012; Inouye & Charpentier, 1996; Voyer et al., 2009b; Voyer et al., 2011).
A state-of-the-art review of multiple aspects of delirium including etiology
reviews from original published articles of validated risk prediction models between 1990
and 2012 was published by Inouye and colleagues in 2014. The review focused on
primary articles including articles from a reference list of systematic reviews and metaanalysis.
The interrelationship of the validated multifactorial model was described and it
reinforced the multifactorial impact in triggering the onset of the delirium syndrome
(Inouye et al., 2014). The more vulnerable the patient is (multiple predisposing factors)
the least amount (benign) the insult (lower degree precipitating factor/modifiable) will be
needed to create the right combination that could catapult a patient into a delirious state.
The opposite is also true; the non-vulnerable patient (minimal predisposing factor) will
require a significant number of precipitating factors to trigger delirium.

22
A review of other prospective, validated predictive models identifying
predisposing and precipitating factors was also conducted. The populations of the 11
studies extended from general medical, surgical (non-cardiac and cardiac), ICU. The risk
factors reported included 11 predisposing factors and 10 categories of precipitating
factors. The review reinforced that of the 11 predisposing factors reported, the highest
risk for the onset of delirium was found in the general medical and non-cardiac surgical
population and included dementia or cognitive impairment, advanced age (> 70),
functional impairment, vision impairment, and alcohol abuse (Inouye, Westendorp, et al.,
2014). Importantly, comorbidity burden or specific comorbidities such as stroke and
depression were risk factors for triggering delirium in all populations and a 40% to 500%
increased risk with reported abnormal lab values affected all populations. Precipitating
factors had more variation among the populations studied. Of the 10 precipitating factors
reported, there was a 4.5 times increased risk of developing delirium in the medical
population who were exposed to the following precipitating factors: polypharmacy,
psychoactive medication, and physical restraints.
This review did not include all diseases, especially neurological diseases that
contribute to the delirium syndrome. The other critical population not included in this
review is the PAC/LTC population, which is growing rapidly and at high risk for
delirium. Findings from this study provided information regarding the impact of risk
factors, the interrelationship between predisposing and predictors, and what to consider
when developing intervention strategies for clinicians.
Comorbidities
With the advancement of technology, medication, and healthcare practice, adults
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are living longer with chronic diseases and surviving intensive care and acute care
hospitalization. In LTC settings, comorbidity is associated with the duration of delirium
and mortality (Arinzon et al., 2011). Duration of delirium was associated with multiple
variables including number of comorbid diseases, specifically, congestive heart failure
(CHF), chronic renal failure (CRF), and previous cerebral vascular accident (CVA).
Multiple variables were also associated with mortality that included CHF, cardiovascular
disease (CVD), and pulmonary disease (Arinzon et al., 2011). One study reported an
association between delirium symptoms and comorbidity in the PAC setting that included
both rehabilitation hospitals and skilled nursing care facilities (Marcantonio et al., 2003).
Interestingly, another study reported medical illness was not associated with delirium in
LTC and is inconsistent with studies in acute care (McCusker et al., 2011b).
Long Term Care
Delirium has been identified in the LTC setting. However, because of the
different “homelike” environmental setting compared to the acute care hospital setting
and population, risk factors from acute care cannot be generalizable to LTC (Voyer et al.,
2011, p. 172). Voyer, Richard, Doucet, and Carmichael (2009b, 2011) investigated both
the precipitating and predisposing factors in the LTC setting in two separate studies using
the same population. Both studies were a cross-sectional design including 155 residents
with delirium and dementia, three LTC facilities, and one hospital-based LTC all located
in Quebec, Canada.
Voyer and colleagues (2011) studied precipitating factors of LTC residents. The
two aims were to identify precipitating factors associated with delirium and to assess the
number of precipitating factors that contribute to the onset of delirium. Validated and
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widely used instruments used were the Confusion Assessment Method (CAM) to identify
delirium (sensitivity 94% to 100%; specificity 90% to 95%) and the Hierarchic Dementia
Scale (HDS) to measure the severity of dementia. The precipitating factors assessed in
this study included physical restraint (observed), sensory stimulation (13-item, 3-point
scale questionnaire), physical environment (11-item questionnaire), iatrogenic events
(adding number for each resident), physical activity (4-item questionnaire) and
medications (narcotics, benzodiazepines, antipsychotics, antidepressants) within a 24hour time period. All assessments were obtained during 7-hour observation period. The
other variables assessed were comorbidity, using the Charlson Comorbidity Index (CCI)
and functional autonomy with the Functional Autonomy Measurement System (SMAF).
The results reported for delirium occurrence and comorbidity among resident
were high: 70.3% and 84% respectively (Voyer et al., 2011). The resulted precipitating
factors significantly associated with delirium were 3 of the 10 assessed: physical
restraints (the most strongly associated) (OR 3.46; CI 1.65-7.22; p <. 05), sensory
stimulation (OR 0.79; CI 0.62-0.99; p<. 05), and adequacy of physical environment (OR
0.66; CI 0.50- 0.87; p < .05) (Voyer et al., 2011). Further testing of restraints and
association of delirium included multivariate analysis (OR 4.64; CI 2.62-8.27), indicating
a 464% odds of being delirious. A risk score to determine the number of variables that
were associated with the risk of developing delirium reported an OR 2.53% (CI 1.4-4.49)
or a 253% increased risk. The analysis to determine number of precipitating factors that
affect the onset of delirium was a logistic regression model controlling for physical
restraints. The analysis identified two precipitating factors will have a 6-fold greater
odds of delirium as compared to no precipitating factors. This population had 76%
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residents with delirium and 2 precipitating factors. The percentage of residents with
delirium increased to 90% with 3 precipitating factors. The residents with high
prevalence of dementia made this vulnerable population at increased risk of developing
delirium, which is consistent with the multifactorial model (Voyer et al., 2011).
Predisposing factors were explored (Voyer et al., 2009b). The same instruments
assessing for delirium and severity of dementia as mentioned in above study were used
(Voyer et al., 2009b, 2011). The predisposing factors included pain, depression,
comorbidity, behavior problems, functional autonomy, number of medications,
dehydration, fever, malnutrition, sleep problems, and visual and hearing impairment. The
total number of predisposing factors tested using a bivariate analysis were 21 and 9 (age,
severity of dementia, level of functional autonomy, number of medications, pain,
behavioral problems, dehydration, brachial perimeter, geriatric fever) and were associated
with delirium (Voyer et al., 2009b). The multivariate analysis revealed that age (OR
1.07; CI 1.05-1.10) and severity of dementia (OR 1.05%; CI 1.03-1.07; p < .05) were
associated with delirium. Each study provided a strong training program to provide
standard approach for the study nurse a good interrater reliability, used reliable
instruments that reported validated data, and measured the appropriate variable. Neither
study included the LTC rehabilitation patient population.
There is a difference between the two populations regarding various factors that
contribute to the risk of developing delirium in these settings. In both the acute care and
LTC populations, the onset of delirium is most often multifactorial involving both
predisposing and precipitating factors. The common predisposing factor between acute
care and LTC were dementia/cognitive impairment, advanced age, and functional
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autonomy. The precipitating factor identified in both acute care and LTC was physical
restraints. The LTC had nine predisposing factors but only three were congruent with
acute care.
Screening
In the clinical setting, delirium frequently goes undetected by the clinical staff.
One study noted that 50% of cases are undiagnosed (Volland & Fisher, 2015). To
improve delirium identification, a delirium-screening instrument is essential. Elliott
(2014) reported that if a delirium instrument was not employed, as much as two-thirds of
delirium went undetected. Different terms are used interchangeably at times with
delirium. Those can include ICU psychosis, acute mental status change, acute confusion,
and postoperative psychosis. These terms may affect diagnosing delirium and contribute
to a delay in appropriate care measures that need to be taken (Volland & Fisher, 2015).
The identification of delirium is complex and the presentation can be
multifaceted. The challenge is determining if the cognitive change is due to dementia,
psychotic disorder, neurovascular insult, or a complication of a systematic illness (Miller,
2008). To determine what is occurring, it is imperative to routinely conduct an
assessment using appropriate instruments by trained staff (Kukreja et al., 2015).
National guidelines have clearly identified a systematic approach in assessing for
delirium including the frequency of needed assessments (Elliott, 2014). Multiple, wellestablished, widely used, and reliable/valid screening instruments for delirium are
currently available. Consistent compliance with the guidelines and appropriate utilization
of the available instruments is still needed (Elliott, 2014; Voyer et al., 2015). One
systematic review identified six validated instruments to assess for delirium including
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Cognitive Test for Delirium, abbreviated Cognitive Test for Delirium, Confusion
Assessment Method for Intensive Care Unit (CAM-ICU), Intensive Care Delirium
Screening Checklist, Neelon and Champagne Confusion Scale, and Delirium Detection
Score (Cavallazzi et al., 2012).
The CAM-ICU is the most studied and widely used instrument in the ICU to
assess for delirium. This instrument measures 4 key features: acute onset or fluctuating
course, inattention, disorganized thinking, and altered level of consciousness (Cavallazzi
et al., 2012). By using the CAM-ICU, the diagnosis of delirium was improved with a
reported 87% of ICU patients and 83% of mechanically ventilated patients experiencing
delirium (Ely, Inouye, et al., 2001; Ely, Margolin, et al., 2001). Van Velthuijsen et al.,
(2016) conducted a systematic review assessing the validity, reliability, and feasibility of
delirium identification instruments in the older adult hospitalized patient. Forty-three
studies were reviewed and 28 instruments met the criteria for inclusion. The studies were
categorized as follows: 10 observational, 6 interactive and 12 mixed. The deliriumscreening instruments population application was described as two ICU (CAM-ICU,
Intensive Care Delirium Screening Checklist (ICDSC) and one emergency department
(modified CAM for the Emergency Department; mCAMed). The instruments can be
divided into two categories to screen for delirium: trained professionals and
family/informal caregiver (Delirium scale (I-AGeD); Family-CAM (FAM-CAM); Simple
Question in Delirium (SQiD).
Delirium Observation Screening Scale (DOS) is a highly valid and reliable
instrument utilized by nurses and has a reported sensitivity of 89% to 100%, with
specificity at 87% and 97%, interrater reliability (Spearman r-0.54) and internal
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consistency (Cronbach’s α=0.93 to 0.96) (van Velthuijsen et al., 2016). The Nursing
Delirium Screening Scale (Nu-DESC) as the name of the instrument implies, is
implemented by nurses and has a sensitivity ranging 32% to 96%; specificity ranging
69% to 92%, an interrater reliability a-0.94 (van Velthuijsen et al., 2016). CAM, the
most validated and used delirium screening instrument, has sensitivity ranging 46% to
94%, specificity ranging 63% to 100%, interrater reliability kappa 0.65 to 1.00 and
implemented by nurses (van Velthuijsen et al., 2016). CAM-ICU, a highly validated and
reliable delirium screening instrument specifically for the ICU patient population, has a
sensitivity ranging 28% to 92%, specificity ranging 89% to 99%, interrater reliability
kappa ranging 0.81 to 0.94 and implemented by nurses (van Velthuijsen et al., 2016).
The Delirium Rating Scale Revised-98 (DRS-R-98) instrument was designed to screen
for delirium and determine symptom severity (van Velthuijsen et al., 2016). The
instrument DRS-R-98 is implemented by clinicians (not nurses) and has a reported
sensitivity ranging 56% to 93%, specificity ranging 82% to 98%, interrater reliability
ranging 0.92 to 1.00, and internal consistency a=0.91 to 0.94 (van Velthuijsen et al.,
2016). The family/informal caregiver instruments also have been validated. FAM-CAM
has a reported sensitivity 75% and specificity 91%. Single Question in Validity (SQiD)
has a reported sensitivity of 77% and specificity 51% (van Velthuijsen et al., 2016). The
researchers measured many other instruments but only had one validation study so no indepth reporting was provided.
In summary, the review of instruments used in the management of delirium
provided information about what instruments are available, what they are used for, and
offered a guide to researchers on the most appropriate setting in which the instrument can
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be implemented to identify delirium. The instruments were reported to have a sensitivity
and specificity of ≥ 80% and all could be completed within a short timeframe. It is not
only essential to have a reliable and sensitive instrument but to have one that will be
utilized by the staff. The CAM is the most widely used, with high reliability and validity,
for delirium-screening in both medical and surgical patients, used in various settings
including ED and ICU, and implemented by nurses. The FAM-CAM instrument obtains
the family/informal caregivers' participation is assessing for delirium to assist with early
recognition. The most widely used instrument for identifying delirium-severity is the
DRS-98. The combination of observational and interactive items in delirium-screening
instruments is most useful for diagnostic means for physicians (van Velthuijsen et al.,
2016).
Length of Stay
Increased LOS has been reported in patients with delirium as compared to patients
without delirium. There are several studies indicating that delirium in the acute care
setting has a deleterious impact by extending LOS (Marcantonio, Flacker, Michaels, &
Resnick, 2000; Marcantonio et al., 2003; McCusker, Cole, Dendukuri, & Belzile, 2003).
One study reported a significant increased LOS in prevalent subsyndromal delirium cases
in the acute care setting (Cole, McCusker, Dendukuri, & Han, 2003). Inouye et al.
(1999) conducted an intervention study evaluating the effectiveness of the
multicomponent program that implemented strategies to address delirium risk factors to
prevent delirium. The LOS was measured by days resulting in a similar mean for both
intervention 7 days and usual care 6.5 days (Inouye et al., 1999).
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McCusker et al. (2003) investigated the impact delirium has on LOS over a 12month timeframe identifying patients via a two-step process: screening interview and
chart review of documented delirium symptoms in nurses' notes. They evaluated 359
patients (age ≥ 65 years) resulting in 241 with delirium admitted to a Canadian university
acute care hospital during the first week (excluding ICU, oncology or stroke patients).
For patients with prevalent delirium (adjusting for a diagnosis of dementia), results
indicated there was no significance in LOS between prevalent and non-delirium matched
control groups. The median and interquartile ranges (13.0, 7.0-21.0; 8.0, 5.0-7.0,
respectively) identified patients with prevalent delirium. Their population had a large
portion with dementia from a skilled nursing facility. The incident cases did have
significance in LOS, 8 days longer, between the incident delirium and matched control
group reporting median and interquartile (16.5, 11.0-23.0; 7.5, 4.0-15.0, respectively)
with and without adjustments (McCusker et al., 2003). It was the interaction between
delirium and dementia that contributed to increased LOS (McCusker et al., 2003). The
researcher did identify that one instrument, IQCODE, used to detect dementia, had not
been validated with delirium population. A strength of the study is the large sample size
that provided the researcher a 99% power to detect LOS between incident delirium and
matched controls (McCusker et al., 2003).
Stroke patients can also present with delirium; however, there is a paucity of
information on the outcomes in this group. A systematic review and meta-analysis
reviewed relevant articles through 2011 to evaluate outcomes of stroke patients with
delirium in an acute hospital, inpatient mortality, 12-month mortality, institutionalization,
and LOS (Shi, Quiyun et al., 2012). Ten studies met the criteria for inclusion and a total
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of 2,004 patients were included in the review. The LOS was reported to be greater in the
six studies (n=1,290 patients). The researchers calculated the LOS from two studies by
computing both study results. The LOS was higher, 9 days longer (mean difference 9.39
days, 95% CI 6.67-12.11), when patients developed delirium as compared to patients
without delirium (Shi, Presutti, Selchen, & Saposnik, 2012).
Intensive Care Unit
The delirious patient is at greater risk of experiencing a sequelae. One study
reported a 3.2 increase in 6-month mortality and a twofold increase in the length of
hospitalization (Cavallazzi et al., 2012). The ICU patient with delirium has potentially
both short-term and long-term sequelae. The short-term outcomes include confusion,
agitation, sleep-wake cycle disturbance, and disorientation. The delirious patient has a
longer ICU stay, increased and heavier use of sedation, physical restraints, increased
mortality, and increased falls (Kukreja et al., 2015). At 6 months, post-operative SICU
patients with delirium had 3.2 times higher mortality, increased personal activity of daily
living (ADL) dependency (p<0.001), and negatively impacted quality of life (Abelha et
al., 2013).
The long-term consequences have been reported as far out as 12 months following
the older adult patient’s hospitalization. The patient with delirium may experience both
physical and cognitive decline, institutionalization, and higher mortality (Kukreja et al.,
2015). One study reported of the 55 patients studied, 78% of the critical care survivors
developed impairment in memory, attention, concentration and/or mental processing
speed 1 year after mechanical ventilation. Also there is evidence of dementia-like
symptoms following ICU stay (Girard et al, 2010). Rothenhäusler, Ehrentraut, Stoll,
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Schelling, & Kapfhammer (2001) studied patients who survived acute respiratory distress
syndrome over 10 years and identified 24% had cognitive impairment that affected their
ability to return to work and poor health. Another study evaluated patients who had heavy
sedation and after 1 year; 34% had cognitive scores at the level of brain injury and 24%
had scores similar to Alzheimer’s patients (Pandharipande et al., 2013).
Post-Acute Care
Marcantonio et al. (2003) conducted a study to identify the prevalence of delirium
upon admission, delirium persistence, and functional recovery associated with delirium
upon admission to PAC settings (85 PAC: 55 rehabilitation and 30 skilled nursing
facilities) in 29 states that included 551 residents age ≥ 65 years. The study was a field
validation study testing the Minimum Data Set for Post-Acute Care (MDS-PAC) from
December 1998 to February 1999. The bedside staff was trained to use the MDS-PAC
and implemented the screening within 4 days of admission followed by a random patient
selection to conduct another MDS-PAC assessment on the 11th or 18th day from
admission. The total number of symptoms was assessed within one week from admission
and measured as more, less, or none compared to admission assessment. Functional status
was also reported on both admission and 1-week utilizing the ADL and instrumental
activity of daily living (IADL) MDS-PAC. Delirium assessment reported results included
23% overall prevalence; 1 week follow-up assessment, 14% resolved, 22% decreased
symptoms, 52% no change, 12% increased symptoms and 4% incidence (new
occurrence). The delirium occurrence is strongly associated with dementia (p <. 01) and
comorbidity (p.01). Functional recovery was worse, ADL change 3.6, CI 2.2-5.0; IADL
change 2.6, CI 1.4-3.6, with the same or increased delirium symptoms compared to
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decreased or resolved symptoms.
Treatment/Intervention
Delirium is more often attributed to a multifactorial verses single factor cause and
30% to 40% of the cases are considered preventable (Inouye et al., 1999). In each
program attempting to effectively decrease the risk, occurrence, and negative outcomes
of delirium, it is important to enlist both preventative and treatment protocols (Huson et
al., 2016). Treatment should be focused on the underlying causes and risk factors
contributing to the onset of delirium and may include acute medical illness, adverse
event, or drug intoxication (Huson et al., 2016). By knowing what precipitating factors
contribute to the delirium onset, clinicians can initiate the appropriate management of the
risk factor. The treatment strategies can be broken into two segments: nonpharmacological and pharmacological. Preferably, initiating non-pharmacological
intervention should be done, making it the first-line treatment strategy (Fong, Tulebaev,
et al., 2009). Pharmacological intervention should be implemented when nonpharmacological interventions have failed or when there is an urgent need to prevent
harm to the patient, either medically or psychologically (Cavallazzi et al., 2012).
Nonpharmacological Management
Nonpharmacological management has been effective in preventing and reducing
the symptoms of delirium. One study showed a 40% decrease in the odds of developing
delirium (Kukreja et al., 2015). Strategies to address risk factors include management of
dehydration, immobility, sleep disturbance, and visual and hearing impairment.
Environmental factors are critical to address to prevent or reduce the onset of delirium.
The environmental aspects to modify include appropriate light exposure during the day,
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minimize light during the night, and temperature control and noise level, especially at
night, which can contribute to the disruption of sleep (Kukreja et al., 2015).
A pioneer intervention study assessed the effectiveness of a multicomponent
program, Elder Life program, determined adherence to the program and the impact on the
risk factors determined in the acute care setting (Inouye et al., 1999). The prospective
individual-matching studied population were patients admitted to a non-critical care
urban teaching hospital located in Connecticut (Inouye et al., 1999). The study
implemented standard intervention protocol to address 6 risk factors (cognitive
impairment, sleep deprivation, immobility, visual impairment, hearing impairment and
dehydration) with the ultimate goal to reduce the incidence of delirium. Overall, the
intervention group had a significant decrease in delirium than the usual care group (9.9%)
verses usual care (15%) and match odds ratio 0.60 (95% CI 0.39 to 0.92), p=0.02 (Inouye
et al., 1999). Overall compliance with the intervention protocols was 87% and reasons
for non-adherence was multifactorial: patient refusal, patient not available, intervention
staff not available, and medical contraindications resulting in less risk factors in the
intervention group (Inouye et al., 1999). This study was instrumental in identifying
prevention as the primary effective strategy to reduce risk of delirium (Inouye et al.,
1999). This study did not include PAC or LTC.
Post-Acute Care
There have been many studies to address delirium in the acute care setting and
development of intervention/prevention delirium programs but few have been explored in
LTC/PAC. Due to the specialty environment of the LTC and PAC settings, the adoption
of the models developed for acute care may not be effective in the PAC setting.
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Bergmann, Murphy, Kiely, Jones, & Marcantonio (2005) described the Delirium
Abatement Program (DAP) developed in 2000 that addresses persistent delirium
specifically in the PAC setting. The primary goal of the DAP is to reduce the duration of
delirium and improve functional recovery. The DAP was implemented in eight skilled
nursing facilities with separate dedicated units for skilled nursing care and rehabilitation
care. The patient population consisted of patients admitted directly from acute care
following a medical or surgical hospitalization. Screening for delirium took place within
five days of admission and previous prevalence for delirium and dementia was reported
16% in skilled nursing care and 33% in rehabilitation care. An experienced research
nurse provided consultation in the implementation of DAP in the PAC units of each of
the skilled nursing care facilities. The benefit in implementing DAP is the standardization
in the PAC unit in the following areas: delirium screening, assessment and treatment of
possible causes, prevention and management, and restoration of patient cognitive and
self-care function (Bergmann et al., 2005).
A mixed methods with a repeated measure study by Huson et al. (2016) evaluated
the impact of implementing a multicomponent intervention program aimed at preventing
delirium and functional decline in the older adult patient (≥ 70 years) in a PAC
rehabilitation hospital. The Hospital Elder Life Program (HELP) has provided positive
results in the acute care hospital setting (medical unit, geriatric unit, surgical unit) but this
was the first PAC setting. The qualitative method of this study utilized a purposeful
sampling for a total of 6 patients that participated in the study. Caregivers (of the patients
in the program), volunteers, and staff participated in a focus group interview.
The reduction of delirium was greater in the intervention group (10.9%
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admission/ 2.5% at discharge) compared to the usual care group (2.5% admission / 2.5%
at discharge), LOS was lower in HELP group (52.3 versus 59.2; p = .244), significant
improvement in short-term memory and recall in the intervention group mean 0.8 –0.1
usual group; p = .006); FIM 25.9% improvement intervention group and 20.9%
improvement; p = .188) and rehabilitation efficiency 0.5 intervention group and 0.4 usual
care group; p =. 381.
Inouye, Marcantonio, and Metzger (2014) conducted a thorough review of
delirium in the elderly. Prevention and treatment were reviewed and reinforced the
positive impact HELP, the most widely adopted multicomponent intervention strategy,
has had on the reduction of delirium and functional impairment. With the wide
implementation of the program in greater than 200 hospitals, the studies have revealed a
cost-effective method in preventing delirium. Although this program has been adopted in
various healthcare settings none has been reported as being adopted in the LTC
rehabilitation setting.
Although HELP has been well disseminated in over 200 hospitals globally, there
are other nonpharmacological interventions. A proactive geriatric consultation to address
management of surgical patients pre- and post-op had a positive result in an RCT.
Additional interventions that have shown to be effective included geriatric units
multifactorial intervention, interdisciplinary consults, family conducted intervention,
education of staff, and rehabilitation intervention. (Inouye, Westendorp, et al., 2014).
Other nonpharmacological interventions are earplugs at night (enhance sleep factor) and
the Delirium room, which are promising but lacked rigor in the studies at this time. The
scientific criteria used to critique the published articles included: “≥ 25 patients in each

37
intervention and control group, prospective sampling framework, validated delirium
assessment and achieved a modified Jadad score” (Inouye, Westerndorp, et al., 2014, p.
8).
Pharmacological Interventions
The pharmacological prevention and treatment publications were evaluated using
the same methods as stated for non-pharmacological strategies. The concern is that the
antipsychotics and sedations will only modify the level of agitation or behavioral
symptoms resulting in moving from hyperactive to hypoactive delirium (Inouye,
Westendorp, et al., 2014). Hypoactive syndrome is associated with worse outcomes.
Due to the lack of rigor or reproducible evidence, the researchers could not make
recommendations for the pharmacological use in delirium prevention or treatment. The
researchers do recommend the best approach is a “multipronged nonpharmacological
approach, such as cognitive rehabilitation, drug reduction or drug sparing approaches
(i.e., substituting less toxic neuroprotection, sleep enhancement (e.g. melatonin), and
reduction of pain and stress including complementary and alternative medicine” (Inouye,
Westendorp, et al., 2014 p. 11).
Review of the patient’s medications is critical. Reducing, eliminating, or
substituting the current medication regime may decrease the symptoms of delirium. The
implementation of medication such as antipsychotics on a short-term basis and at the
lowest dose has been shown to reduce the duration of delirium (Kukreja et al., 2015). To
manage behavioral changes low doses of haloperidol is the drug of choice.
Medication Management
Medications, especially psychotropic and polypharmacy, have been associated
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with the onset of delirium and adverse outcomes. Baby boomers 65 and older have
become the largest population in the healthcare system and will contribute to the
alarming incidence of medication adverse events and delirium. Medications may
contribute to the onset of delirium in12%-39% delirium cases, and are considered the
most preventable trigger in the development of delirium (Hein et al., 2014). Between
1997 and 2008, one study reported a 96% increase in drug-related admission in the 65 to
84 year old adult population (Morandi et al., 2013). They also indicated approximately
50% of the hospital admissions related to adverse drug events occurred in the 80 or older
adult population.
As the older adult develops the onset of diseases related to aging, there is also an
increased use of medications to treat chronic diseases. The challenge is for physicians to
be cognizant of medications that are necessary to treat the patient and understand the
drug-to-drug interactions. The medications prescribed may be the right medication for the
clinical event; however, with improved clinical condition, the medication may no longer
be needed. Morandi et al. (2013) indicated 50% of the hospitalized older adults would be
discharged home with at least one potentially inappropriate medication (PIM) and one
actual inappropriate medication (AIM). Interestingly, 50% of PIMs and 59% AIMs were
first prescribed while in the ICU.
Treating the older adult ICU patient is complex and often requires multiple
medications to help them survive their critical illness. During their critical health crisis,
the clinical benefit of the medications prescribed outweigh the risk of delirium. However,
once the patient improves, it is important for clinicians to assess the patients’ medications
and determine the need for those medications, the risk, and the drug-to-drug interaction.
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This will reduce the risk of developing delirium and ensure the most appropriate
medications are prescribed for the patient including at the time of discharge. (Morandi et
al., 2013).
The American Geriatrics Society Beers Criteria Update Expert Panel (2015)
reviewed the medications that are used for the older adult and developed criteria to help
drive safe medication practice in this population. The objective was to update the PIMs to
ensure safe prescribing practices for the older adult. There have been adverse events
associated with PIM that include confusion, falls, and mortality. To reduce the risk of
poor patient outcomes related to medications, the update included medication dose
adjustment related to kidney function and drug-to-drug interaction. The criteria will not
only provide safe medication practice patterns for practitioners working with the older
adult but will also be a multipronged resource to educate clinicians, patients, and families
in the appropriate selection of medications, provide a means to track cost, medication
usage in the older adult population, and drive quality of care. The criteria will help guide
care for the older adult (≥ 65 years) in all settings (acute care, outpatient, institutionalized
care) excluding hospice and palliative care (The American Geriatrics Society Beers
Criteria Update Expert Panel, 2015).
Psychotropic Medications
There is controversy surrounding the use of antipsychotic medications in the
prevention or treatment of delirium (Inouye, Westendorp, et al., 2014). For every
recommended treatment it is essential to have well-supported evidence demonstrating the
benefits outweigh the risk of harm and currently there is no reproducible evidence that
clearly demonstrates antipsychotic effectiveness in prevention or treatment of delirium
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(Inouye, Marcantonio, et al., 2014; Inouye, Westendorp, et al., 2014). The American
Geriatrics Society Beers Criteria Update Expert Panel (2015) identified antipsychotic
medications as a PIM due to the lack of consistent scientific evidence of effectiveness
and risk of drug-related adverse events. This panel has recommended that if an
antipsychotic medication is used in the treatment of delirium, it should not be the first
line of treatment and used only if nonpharmacological methods have proven ineffective
or cannot be implemented. In the LTC population, there have been safety concerns with
the high use of antipsychotic use (Chen, 2010). The Food and Drug Administration
issued a black box warning on antipsychotic use in 2005 for older adult patients with
dementia and another warning in 2007 for all antipsychotic use due to the high
association of antipsychotic medications and mortality (Chen, 2010; Jung, Meucci,
Unruh, Mor, & Dosa, 2013). To evaluate the antipsychotic use in the Medicare
beneficiaries in LTC, the Office of Inspector General investigated LTC facilities in 2011,
revealing 14% of residents were on atypical antipsychotic, 83% were off-label
indications, and 88% had dementia even following the black box warning placed in 2005
and 2007 (Urick, Kaskie, & Carnahan, 2016).
A systematic review conducted by Flaherty, Gonzales, and Dong in 2011
examined 13 studies, six on a single-agent (drug) and seven comparing two agents (drug)
with varying number of participants in the treatment arms; 62% (8 studies) had < 25 and
15% (2) had > 70. The antipsychotic medications included haloperiodol, quetiapine,
risperidone, olanzapine, mianserin (not available in U.S.), perospirone (not available in
U.S.), and amisulpride (an antidepressant-different than atypical or conventional
antipsychotic). The instruments used to diagnosis delirium were the Diagnostic and
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Statistical Manual of Mental Disorders Fourth Edition (DSM-IV) (12 studies) and DSMIII-R (1 study). Both instruments are widely used and well-validated.
The ability to draw conclusions regarding the effectiveness of the studies was
compromised and the lack of a control group is challenging with the wide variation and
lack of key description of the methods used for each of the studies. The sample size was
generally small and from a variety of countries. No LTC rehabilitation or PAC
populations were included in this study.
Anderson, Greer, MacDonald, Rutks, & Tacklind, (2011) also conducted a
systematic review with similar results. The pharmacological studies were unable to
determine if the drug was effective in preventing delirium. The small sample sizes, select
population, and inconsistency or incompleteness of recording outcomes were all reported
(Anderson et al., 2011). Again, there were no LTC rehabilitation or PAC settings in this
study.
Transition from acute care to LTC and skilled rehabilitation facilities has an
increased risk of residents being admitted with delirium. The delirium may have a
negative impact on the resident’s functional recovery and care (Syed & MessingerRapport, 2013). The management of delirium and/or dementia has a pharmacological
approach to treat the hyperactive behavioral disturbances of the LTC resident who has
delirium and or dementia (Hopewell et al., 2016; Pasina et al., 2016; Syed & MessingerRapport, 2013). A major concern was the reported high use of psychotropic medication
in the LTC and the mixed reports of its impact on the resident outcomes (U. S.
Government Accountability Office, 2015).
A retrospective, longitudinal cohort study described how the dose and duration of
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antipsychotics impacts mortality risk in nursing home residents with a stay greater
than100 consecutive days (Simoni-Wastila et al., 2016). All residents received
psychotropic medications for three different health conditions: severe mental illness
(SMI; n= 5,621), dementia with behavioral symptoms but without SMI (n= 1,090), or
delirium with behavioral symptoms only without SMI or dementia (n=2,100). The data
were retrieved from 2006 to 2009, merged data sources and a 5% random sample of
Medicare claims data and Minimum Data Set (MDS) vs 2.0 (Simoni-Wastila et al.,
2016). The International Classification of Diseases, Ninth Revision, Clinical
Modification (ICD-9-CM) codes were used to obtain the Medicare part A (10 diagnoses)
and Medicare part B (9 diagnoses). All three cohorts used antipsychotic agents and 90%
of them used atypical agents; quetiapine and risperidone were used by one third of this
group. Typical antipsychotic agents were used for in 5 residents and haloperidol was the
most common. Duration of the antipsychotic was lower in the delirium cohort compared
to SMI cohort and dementia+behavior that had the same longer duration. Mortality risk is
highest within the 30 days of initiating the antipsychotic agent for the SMI cohort and
less than 7 days for the delirium cohort. The mortality risk was lower in SMI cohort and
delirium cohort both with a longer duration of 91-184 days. Interestingly, the relationship
between mortality risk and antipsychotic duration did not have a significant relationship
in the dementia+behavior cohort (Simoni-Wastila et al., 2016).
Polypharmacy. Polypharmacy is a precipitating factor to the onset of delirium.
There is no official standard definition but an accepted general definition “concurrent use
of several prescription medications” (Hein et al., 2014, p. 850.e12) and there is no clear
agreement on the number of medications. Some researchers have used 3 to 5 medications
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while others report using 9 or more (Hein et al., 2014). The researchers conducted a
prospective cohort study in an acute care geriatric ward of a university hospital with 410
patients over a 9-month period in order to ascertain the association of delirium with
polypharmacy. The investigation included an assessment of delirium using the highly
sensitivity, specificity, validated and widely used CAM instrument within 72 hours of
admission. Patients taking more than five medications were included in the study and
compared to the control group that were taking less than six medications. Compared with
the control group, delirium was significantly identified more often in patients receiving
polypharmacy medications versus not receiving polypharmacy, 69% and 30%
respectively and a relative risk of 2.33, (CI 1.23-4.41; p < .010). Delirium was
significantly associated with age and dementia in patients admitted from an acute care
hospital (OR 2.15; CI 0.15-3.99; p <. 016 and OR 3.6; CI 1.74-5.72; p< .001)
respectively.
The study successfully identified polypharmacy’s association with delirium
independent of type of medication. Interestingly, there was no relationship between
comorbidity and polypharmacy, which varied from previous studies (Hein et al., 2014).
This study population did not include other elderly populations such as those in
PAC/LTC facilities and there was no separation of prevalence and incidence of delirium
that is important in determining intervention/preventative care. The significant
relationship of age and dementia in the development of delirium was reported and
consistent with other studies.
The number of medications a resident is prescribed is a predictor of the
occurrence of delirium for the resident during their LTC visit (Voyer et al., 2009b).
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Inouye and Charpentier (1996) identified the increased risk of developing delirium when
three or more medications were added to the patients’ care.
Post-Acute Care/Long Term Care Rehabilitation
There is a paucity of research studies that focus on delirium in LTC and even
fewer in the LTC rehabilitation population. The patient population is changing; the trend
primarily is an increasing number of patients requiring recovery in LTC or PAC and
shorter LOS in the acute care setting (Marcantonio et al., 2005). Upon admission, the
LTC/PAC patient has an increased prevalence of delirium. Knowing the negative patient
outcomes once a patient has delirium, there is an increased risk of sequelae events
occurring in the LTC and post-acute facilities.
The following studies were conducted in LTC facilities with both skilled nursing
care and PAC units and evaluated different aspects of delirium in the same population.
The residents in these studies were exclusively from the PAC unit. The
prevalence of delirium, delirium symptoms, and delirium severity was assessed in
residents recruited for a RCT Delirium Abatement Program by Kiely et al. (2003) from
October 2000 to June 2003. The 2,158 recruited patients aged 65 and older were
admitted to an LTC/PAC facility from an acute care hospital. Instruments utilized include
CAM, the Mini-Mental State Examination (MMSE) to assess for cognition (memory,
concentration, attention); Memorial Delirium Assessment Scale (MDAS) to quantify
delirium severity; and the Delirium Symptom Interview (DSI) to identify specific
symptoms of delirium. Delirium categories were divided into four groups based on the
CAM algorithm: full delirium, two or more symptoms, one symptom, and no delirium.
There was a 16% delirium prevalence but the facility reported 9% to 26% delirium upon
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admission. Of the residents, 12% has two or more symptoms and 40% had one symptom.
Interestingly, full delirium had the highest hypoactive or normal psychomotor activity
(37% and 37% respectively). Noted limitations included delirium assessment conducted
within five days and there could be a potential risk of not capturing symptoms on
admission, no outcome data were obtained, and the method section did not state the type
of study. The researchers concluded 16% of this population admitted to PAC from acute
care setting had delirium. The concern raised was whether the PAC staff was prepared to
identify and manage delirium patients in this setting.
Marcantonio et al. (2005) conducted a cohort study in residents with delirium,
subsyndromal delirium, or no delirium and compared outcomes among these groups. A
total of 545 residents, aged 65 and older, admitted to a PAC unit were screened for
delirium and subsyndromal delirium within five days of admission (prevalence 15%)
utilizing the CAM instrument. Other instruments used were the Mini-Mental State
Examination (MMSE) to assess for cognition (memory, concentration, and attention),
Digit Span, and Delirium Symptom Interview (DSI) to identify specific symptoms of
delirium. Residents with delirium were found to be 75% more likely to have one or more
complications than residents without delirium. The complications identified and
compared to residents with and without delirium included a higher 30-day acute care
readmission (30% versus 13%), decreased placement in community within 30 days (30%
versus 70%) and an increased 6-month mortality (25% versus 5.7%) with all
complication results reaching significance (p <. 01). There was a significant (p. <001)
number of residents with preexisting dementia upon admission from acute care but no
difference in comorbidity. Noted study limitations included the delirium assessment
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conducted within five days and review of medical records may not have captured all the
issues if clinicians did not document them; no medications were assessed in the study.
The study strengths included trained research interviewers and chart reviewers.
The impact of delirium resolution on functional recovery was investigated in a
prospective longitudinal study conducted by Kiely et al. (2006). The association between
delirium resolution and functional recovery was studied among 393 PAC residents aged
65 and older and admitted with delirium to a skilled nursing/PAC facility. The
instruments used in this study (CAM, DSI, MDAS, and Charlson Comorbidity) have
already been discussed as they have been used in prior studies. The two exceptions were
the Katz scale (testing functional status) and the Blessed Dementia Rating Scale (BDRS)
(identifying cognitive status prior to hospitalization). The confounding characteristics that
were significantly different with delirium resolution status include > high school
education (p. <02), dementia (p <. 0004), age (p. <04), prehospital cognitive ability (p.
<0001), and delirium severity (p. <0001). The prehospital functional assessment score
resulted in a significant difference compared with delirium resolution status (p < .0001),
and PAC admission had a slightly different result, p < .0007. The functional recovery
compared to delirium resolution status had a significant result of p <. 0001.
There are many delirium instruments utilized in the various healthcare settings.
The most common delirium screening instrument is the CAM (Inouye, Westendorp, et
al., 2014). In LTC, the standard instrument is the minimum data set (MDS), which
contains the CAM (Inouye, Westendorp, et al., 2014). Limited studies conducted in the
LTC setting have utilized various methods to assess and/or screen for delirium in the
LTC population. This variation has made it difficult to compare incidence and prevalence
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of delirium in the LTC population (Culp et al., 1997).
Summary
Delirium has been well studied for the causative factors, treatment, and
prevention to reduce its onset in the acute care setting. There was an opportunity to study
delirium and gender, race, principle admitting diagnosis, polypharmacy, dementia, age,
LOS, Charlson score (comorbidities), and psychotropic medications duration in the older
adult LTC rehabilitation resident. Another relationship to study was between CHARTDEL-derived delirium diagnoses, documented delirium symptoms, and the documented
ICD-10 coded discharge delirium diagnosis. The value of this study to science will
augment previous studies evaluating the association with delirium. The multifactorial
model of delirium in older persons model served as the framework for this study and
guided the evaluation the predisposing factors age, comorbidities and dementia. The
model also guided the evaluation of the precipitating factors polypharmacy and duration
of psychotropic medications.
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Chapter Three
Methodology
This chapter describes the research design and procedures enlisted to investigate
the research aims. The data needed to address this quantitative study were obtained by a
retrospective review of the electronic medical record (EMR) utilizing both a manual
review and an electronic extraction of the data.
Purpose
The purpose of this study was twofold: 1) to describe the relationship between
CHART-DEL-derived delirium diagnosis and the ICD-10 coded discharge delirium
diagnosis; 2) to describe the relationship between delirium (CHART DEL-derived and
ICD-10 ); and the variables of gender, race, principle admitting diagnosis, polypharmacy,
dementia, age, LOS, Charlson score (comorbidities), and psychotropic medications
duration in the LTC rehabilitation residents.
Research Questions
Research questions for this study were:
1. What is the relationship between CHART-DEL-derived delirium diagnosis and
documented ICD-10 coded discharge delirium diagnosis in LTC rehabilitation
residents?
2. What is the relationship between delirium (CHART-DEL-derived and ICD-10)
and the variables of gender, race, principle admitting diagnosis, polypharmacy,
dementia, age, LOS, Charlson score (comorbidities), and psychotropic
medications duration in LTC rehabilitation residents?
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Aims
The aims of this study were to:
1. Describe resident demographic characteristics of gender, race, principal
admitting diagnosis, admit source, discharge disposition, polypharmacy, dementia,
CHART-DEL-derived delirium diagnoses, ICD-10 coded discharge delirium diagnosis,
age, LOS, Charlson score (comorbidities), and psychotropic medications duration.
2a. Describe the relationship between CHART-DEL-derived delirium diagnoses
and the variables of gender, race, principle admitting diagnosis, polypharmacy, dementia,
age, LOS, Charlson score (comorbidities), and psychotropic medications duration.
2b. Describe the relationship between ICD-10 delirium and the variables of
gender, race, principle admitting diagnosis, polypharmacy, dementia, age, LOS, Charlson
score (comorbidities), and psychotropic medications duration.
3a. Determine the odds of having a CHART-DEL-derived delirium diagnosis
based upon gender, race, principle admitting diagnosis, polypharmacy, dementia, age,
LOS, Charlson score (comorbidities), and psychotropic medications duration.
3b. Determine odds of having an ICD-10-derived delirium diagnosis based upon
gender, race, principle admitting diagnosis, polypharmacy, dementia, age, LOS, Charlson
score (comorbidities), and psychotropic medications duration.
Research Design
A retrospective, descriptive correlational design was selected for this study. This
method was selected for the study because it addresses the purpose of the study, which is
to describe the relationships of the variables instead of identifying the causes of the
problem being studied (Polit & Beck, 2012, p. 226). The sample consisted of randomized
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LTC rehabilitation residents who were admitted from January 1, 2016 to December 31,
2016. Study variables were abstracted from the EMR and paper chart. In this study, the
researcher is an objective observer, using a deductive research process that determined
the existence of relationships (Terrell, 2016, p. 136).
Setting / Sample
The site for this study was a hospital-based 100-bed LTC facility with two
resident care units, one 50-bed skilled nursing care (custodial) unit, and one 50-bed
rehabilitation unit, located in Southern California. It admits residents from the acute
setting and is connected to an acute care facility with an adjoining enclosed walkway. In
each specialty unit, skilled nursing, or rehabilitation, the residents were admitted for
medical or surgical care. The 50-bed rehabilitation unit was the setting for this LTC
rehabilitation population.
Inclusion Criteria
The following inclusion criteria were established for this study. Residents were
included if they were:
1. admitted from the hospital to the LTC rehabilitation unit between January 1,
2016 and December 31, 2016
2.

at least 65 years of age

3. a minimum of 48-hour LOS
4. chart review capped at 30-days
Exclusion Criteria
Residents were excluded from the study if they were:
1. admitted to the LTC for skilled nursing care
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2. less than 65 years of age
3. at an LOS of less than 48 hours
4. experiencing eminent terminal illness i.e. 24-hour expired
5. undergoing alcohol withdrawal
Variables and Operational Definitions
Dependent Variable: Delirium diagnosis
The delirium diagnosis was abstracted by full-chart review including notes
documented by all disciplines in both the patient’s paper chart and electronic chart.
Previous hospitalization provided history and physical notes where cognitive baseline
was often identified.
ICD-10. For this study, F05 is the ICD-10 code identifying delirium. ICD-10coded delirium was identified and entered into the resident’s chart following discharge
from the LTC rehabilitation facility. The coders were certified in their role and
maintained annual competencies. The coders abstracted the diagnosis, which assigns the
code and interfaces with billing system. The coders utilized ICD-10 delirium and
included physician documentation such as encephalopathy and confusion codes as
applicable.
CHART-DEL-derived delirium diagnoses. For this study, mental status change,
disorientation, hallucinations, agitation, acute confusion, reversibility of symptoms were
abstracted from the review of all documented notes and utilized the CHART-DELderived delirium diagnoses. The delirium diagnosis was entered as yes/no once the chart
review was completed.
a. “All Confusion Assessment Method (CAM) features are present in the notes (i.e.,
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all four of these features are present: (1) acute onset/fluctuation; (2) inattention;
(3) disorganized thinking or (4) altered level of consciousness” (Xu, Fong, Yee, &
Inouye, 2011, p. 9).
b. “Acute onset of disorientation or hallucinations, especially with evidence of
reversibility or evidence of attribution to medications “in someone with no history
of preexisting cognitive impairment” (Xu et al., 2011, p. 9).
Independent Variables
Demographics were gender, race, principal admitting diagnosis, admit source,
discharge disposition, polypharmacy, dementia, CHART-DEL-derived delirium
diagnoses, and ICD-10-coded discharge delirium diagnosis, age, LOS, Charlson score
(comorbidities), psychotropic medications duration.
Gender. Defined as the “the sex of assignment by oneself or those who raise the
individual” (Hensyl & Cady, 1990, p. 639). The gender will be female or male.
Race. Defined as “a group of animals or individuals within a species which has
common somatic inherited characteristics” (Hensyl & Cady, 1990, p. 1306). The resident
provides this information at time of registration.
Admitting diagnosis. Defined as the “determination of the nature of a disease”
(Hensyl & Cady, 1990, p. 428) by the physician upon being admitted to the LTC
rehabilitation unit.
Admission source. Defined as resident pre-existing living accommodations prior
to being admitted to the hospital.
Discharge Disposition. Defined as placement of resident following discharge.
Polypharmacy. There is no official standard definition but an accepted general
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definition is “concurrent use of several prescription medications” (Hein et al 2014, p.
850.e12) The reported range was 5-10 medications (Roffman, Buchanan, & Allison,
2016) For the purposes of this study, six or more drugs served as the definition of
polypharmacy.
Age. Defined as the “period that has elapsed since birth” (Hensyl & Cady, 1990,
p. 34) ending with the date the chart was reviewed.
LOS. Defined as resident hospital stay from time of admission to discharge. “The
total number of days a participant stays in hospital” (Young et al., 2010, p. 20).
Comorbidities. Defined as “a concomitant but unrelated pathologic or disease
process; usually used in epidemiology to indicate the coexistence of two or more disease
processes” (Hensyl & Cady, 1990, p. 334) defined as the total burden of illnesses
unrelated to the patient’s principal diagnosis.
Charlson score is a valid scoring method to determine risk of mortality and
disease burden. Charlson score has weighted comorbidities ranging from 1 to 6 and the
sum of each weighted comorbidity category provides a score. The score of zero indicates
no comorbidities. The higher the score the greater the risk of mortality and severity of
disease (Roffman et al., 2016)
Psychotropic medication. Defined as “a drug that affects brain activities
associated with mental processes and behavior: categories include anti-psychotics;
antidepressants; antianxiety drugs or anxiolytics; hypnotics” (psychotropic drug, 2002).
Data Sources
Data were obtained from two sources: the EMR and paper chart forms that are not
part of the EMR. Data extracted from the EMR included age, gender, race, Charlson
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score (comorbidities), LOS, disposition, admission source, presence of dementia (ICD-10
code), and International Classification of Disease, 10th revision Clinical Modification
(ICD-10) coded delirium. The data from the paper chart included CHART-DEL-derived
delirium diagnoses, polypharmacy, duration of psychotropic medications, nurse’s notes,
progress notes, emergency department notes, medication administration record, and
neurology or psychiatric consultant notes. In addition, physical therapy, occupational
therapist, speech therapist, and social service notes were reviewed for mentions of
delirium symptomology the electronic chart. Any data where it was noted in the chart as
the resident declined to answer or unknown were labeled as missing.
A data analyst assisted the researcher with EMR data extraction. An initial test
run to pull the data elements was conducted to verify appropriate data procedure. The
researcher worked with the data analyst to address any issues that may arise with the data
pull during the test run.
Data Extraction
The EMR data abstraction was conducted by the data analyst who was instructed
by the researcher to replace patient identifiers with an ID. Encrypted, coded data were
exported to the researcher’s password-protected computer. The data were critically
reviewed by the researcher for any errors or missing data before proceeding to export the
data into analyzing software. A research code ID was placed on the data abstraction
instrument and recorded in a coded logbook. The coded logbook was stored in secured
cabinet in the investigator’s home. The cleaned-up data encrypted coded Microsoft Excel
file was exported into the Statistical Package for the Social Sciences (SPSS) software
version 24.
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The paper chart data were collected onto the chart abstraction instrument for
delirium during hospitalization (see appendix A). Key documented elements abstracted
included acute confusion, source and time of acute confusion, duration of confusion,
agitation, evidence of reversibility or improvement of acute confusion during
hospitalization, and if delirium was present upon admission and during hospitalization.
Data Collection Instruments/Measures
CHART-DEL- derived Delirium Diagnosis Method
This Chart-based Delirium Identification (CHART-DEL) method is designed to
identify delirium (definitive or probable) using clinical chart documentation and no
delirium (possible, uncertain, none) calculating an individual score (Inouye et al., 2005).
It is known that other methods to assess for delirium require more time and resources,
thus increasing cost and time (Xu et al., 2011). The CHART-DEL method can improve
identifying delirium on a broader scale, making it a useful method in many forums
including clinical and both quality improvement and research programs (Xu et al., 2011).
Xu and colleagues (2011) recommended criteria to identify delirium based on
“the level of probability that delirium is truly present” (p. 9) and definite and probable
were used in this study. Voyer et al. (2009a) suggested that using definite and probable
categories are the most appropriate for LTC. The definite criterion is confirmed
diagnosis, unequivocally, determined by an expert rater (Xu et al., 2011). The probable
criterion is that all CAM measures met the acute onset of disorientation or hallucinations
(person without history of impaired cognition) (Xu et al., 2011). The delirium is yes or
no and is an individual score.
The CHART-DEL has a reported sensitivity of 74%, specificity 83%, likelihood
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ratio for a positive result 4.4 and interrater of 82% agreement comparing chart and
interviewer results (Inouye et al., 2005).
Process for this study. The CHART-DEL process was used in this study to
identify delirium using documented symptoms of delirium. For delirium identification,
the EMR was reviewed for documentation of delirium or trigger (words, phrases, signs,
or symptoms) associated with delirium. To address interpreting difficult handwriting, the
researcher rarely consulted the medical record staff to aid in identifying letters or words
and the vast majority of the time the handwriting remained legible. Delirium
identification was confirmed based on the definite or probable criteria. Adjudication was
conducted by the researcher of this study and did not consult with other delirium experts
or utilize consensus to reach agreement (expert panel). Also, no additional screening or
diagnostic instruments were used to identify delirium or other cognitive impairment.

Table 1
Variable and Data Source
Variable

Data Source

Age
Gender
Race/Ethnicity
Length of Stay
Admit Source
Discharge Disposition
Primary Diagnosis Description Code
Charlson Total Score
ICD-10 Dementia
CHART-DEL-Derived Delirium
ICD-10 Delirium
Polypharmacy
Psychotropic Medications Duration (days)

EMR
EMR
EMR
EMR
EMR
EMR
EMR
EMR
EMR
Paper Chart Review
EMR
Paper Chart Review
Paper Chart Review
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Sample Size
The G*Power version 3.1.9 was used to obtain A priori power analysis. Logistic
regression was used to measure potential predictors, independent variables (LOS,
Charlson score [comorbidities], polypharmacy, and duration of psychotropic
medications) of the binary dependent variable (delirium). To measure significance, the
following was used: two-tail; odds ratio 1.8; null 0.15; alpha 0.05; power .80, resulting in
a minimum sample size of 204 residents (Polit, & Beck, 2004, p. 495-496; 537-538).
One-way ANOVA two-tailed statistical model measured the second aim with degrees of
freedom 2, alpha 0.05, power .80, and effect size 0.25 required a minimum sample size of
64. Two-tailed Chi-Square statistical model measured the second aim with degrees of
freedom 1, 3, or 5, alpha 0.05, power .80, and effect size 0.30, and required a minimum
sample size ranging from 87 (2x2 table) to 143 (2x6 table) (Waltz, Strickland, & Lenz,
2017, p. 187 & 196).
Data Analysis
Data were analyzed by entering the data into the SPSS data analysis software,
version 24.
Aim 1. Describe resident demographic characteristics of gender, race, principal
admitting diagnosis, admit source, discharge disposition, polypharmacy, dementia,
CHART-DEL-derived delirium diagnoses, ICD-10 coded discharge delirium diagnosis,
age, LOS, Charlson score (comorbidities), and psychotropic medications duration.
Descriptive statistics were used to analyze these variables.
Aim 2a. Describe the relationship between CHART-DEL-derived delirium
diagnoses and the variables of gender, race, principle admitting diagnosis, polypharmacy,
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dementia, age, LOS, Charlson score (comorbidities), and psychotropic medications
duration. Chi-square (2x2, 2x4, 2x6) and one-way ANOVA were the statistical methods
used.
Aim 2b. Describe the relationship between ICD-10 delirium and the variables of
gender, race, principle admitting diagnosis, polypharmacy, dementia, age, LOS, Charlson
score (comorbidities), and psychotropic medications duration. Chi-square (2x2, 2x4, 2x6)
and one-way ANOVA were the statistical methods used.
Aim 3a. Determine the odds of having a CHART-DEL-derived delirium
diagnosis based upon gender, race, principle admitting diagnosis, polypharmacy,
dementia, age, LOS, Charlson score (comorbidities), and psychotropic medications
duration. Multiple logistic regression was the statistical method used.
Aim 3b. Determine odds of having an ICD-10 derived delirium diagnosis based
upon gender, race, principle admitting diagnosis, polypharmacy, dementia, age, LOS,
Charlson score (comorbidities), and psychotropic medications duration. Multiple logistic
regression was the statistical method used.
Descriptive statistics were used to clearly describe each variable and summarize
the data in a meaningful way (Knapp, 2013). Categorical variables were described using
number and percent (Knapp, 2013). Continuous variables were described using the
number, mean and standard deviation (Knapp, 2013).
Human subjects
The study was approved by the hospital and the university Institutional Review
Boards. To maintain confidentiality, no patient identifiers were recorded and all data
were coded. A research code ID was placed on the data abstraction instrument and
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recorded in a coded logbook. The coded logbook was stored in secured cabinet in the
investigators home. All data will be destroyed 7 years following the study.
Summary
The purpose of this study was to understand the relationship between CHARTDEL-derived delirium diagnosis and the ICD-10 coded delirium and factors associated
with delirium identified from previous studies. Data were obtained from a review of both
the patients’ electronic and paper charts. The patients were hospitalized in an LTC
rehabilitation unit located in southern California. This chapter described the study
method, timeframe of the study, dependent and independent variables, the method of data
analysis and efforts to protect the human subjects’ confidentiality.
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Chapter Four
STUDY REULTS
This chapter begins with a description of the sample followed by findings and
results for each aim along with a corresponding table(s). Several tables display the
findings and highlight levels of significance.
Description of the Sample
The sample consisted of 174 patients discharged between January 1, 2016 and
December 31, 2016, who were at least 65 years old, who had a minimum of 48-hour
LOS, and a chart review cap of 30-days. The review of the residents' charts included
gender, race, principal admitting diagnosis, admit source, discharge disposition,
polypharmacy, dementia, symptoms to generate CHART-DEL-derived delirium
diagnoses, age, LOS, Charlson score (comorbidities), and psychotropic medications
duration. An ICD-10-coded discharge delirium diagnosis was obtained from the EMR
entered by coders. Cases excluded from the study were residents who had been admitted
for skilled nursing care, were less than 65 years of age, had an LOS of less than 48-hours,
had eminent (24 hour) terminal illness, or were undergoing alcohol withdrawal.
Specific Aims and Results
Aim One
Describe resident demographic characteristics of gender, race, principal admitting
diagnosis, admit source, discharge disposition, polypharmacy, dementia, CHART-DELderived delirium diagnoses, ICD-10 coded discharge delirium diagnosis, age, LOS,
Charlson score (comorbidities), and psychotropic medications duration.
The study sample consisted of 174 patients with a mean age of 80.8 (SD = 8.49),
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ranging from 65 to 101.

Table 2
Sample Description (N = 174)
Characteristics

Frequency

%

Gender
Female

108

62.1

Race
White
Hispanic/Latino
Asian
Other

79
53
19
20

46.2
31.0
11.1
11.7

Principal Admitting Diagnosis
Infection
Major system disorder
Neurological
Cancer
Post-surgical
Musculoskeletal

36
28
21
8
46
35

20.7
16.1
12.1
4.6
26.4
20.1

1

99.4
0.6

10
23
12

64.9
9.2
5.8
13.2
6.9

Admit Source
Acute care
SNF discharge/Readmit
Discharge Disposition
Home health
Home/Self care
Skilled nursing
ED short-term acute
Other
Polypharmacy
Yes
ICD-10 Dementia
Yes
No

173

113
16

168

96.6

54
120

31.0
69.0
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CHART-DEL-Derived Delirium
Yes
No

45
129

25.9
74.1

ICD-10 Delirium (F05)
Yes
No

9
165

5.2
94.8

Mean

SD

Age

80.81

8.49

Length of Stay

14.72

6.65

2.13
9.54

1.83
8.34

Charlson Score
Psychotropic Medications Duration
(days)

Note. F05 is the ICD-10 code identifying delirium. CI = confidence interval for mean.

The majority of cases were female (62.1%) with average age of 80.8 years. White
race accounted for 46.2%, with Hispanic/Latino ethnicity accounting for 31% of the
sample. Almost all were admitted from acute care (99.4%) with the top three admitting
diagnoses of post-surgery (26.4%), infection (20.7%), and musculoskeletal diagnosis
(20.1%). Almost all had polypharmacy (96.6%) and 25.8% received psychotropic
medications for 9.5 days. The mean LOS was 14.72 days and discharges to home with
home health accounted for 64.9%. The CHART-DEL-derived delirium diagnosis
identified 25.9% of the time with the ICD-10 code at 5.2%. ICD coding captured 31%
dementia in this sample (see Table 2)
Aim Two
Aim 2a. Describe the relationship between CHART-DEL-derived delirium
diagnoses and the variables of gender, race, principle admitting diagnosis, polypharmacy,
dementia, age, LOS, Charlson score (comorbidities), and psychotropic medications
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duration.
Table 3 organizes the Chi-square test statistics, describing the relationship
between CHART-DEL-derived delirium diagnosis (no/yes), observed frequencies, and
the variables of gender, race, principle admitting diagnosis, polypharmacy, and ICD-10
dementia. The percentage of residents that were identified with CHART-DEL-derived
delirium diagnoses did not differ significantly by gender, race, principle admitting
diagnosis, or dementia. It should be noted that polypharmacy did not meet the minimum
expected count assumption, and therefore, was not used in the logistic regression analysis
for the third study aim.

Table 3
CHART-DEL-Derived Delirium Diagnoses by Resident Characteristics Chi-square
Results
No

Yes

Characteristics

n

%

n

%

Χ2

P

Gender (N = 174)
Male
Female

45
84

34.9
65.1

21
24

46.7
53.3

1.967

.161

Race/Ethnicity (N = 171)
White
Hispanic/Latino
Asian
Other

58
38
14
18

45.3
29.7
10.9
14.1

21
15
5
2

48.8
34.9
11.6
4.7

2.818

.420

Polypharmacy (N = 174)
Yes
No

123
6

95.3
4.7

45
0

100.0
0.0

2.168

.1411

Primary Diagnosis
Description Code (N = 174)
Infection
Major system disorder

24
26

18.6
20.2

12
2

26.7
4.4
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Neurological
Cancer
Post-surgical
Musculoskeletal
ICD-10 Dementia (N = 174)
Yes
No

13
4
34
28

10.1
3.1
26.4
21.7

8
4
12
7

17.8
8.9
26.7
15.6

10.864

.054

37
92

28.7
71.3

17
28

37.8
62.2

1.290

.256

1

Note. Violated the minimum expected count assumption of the model.

One-way ANOVA was used to describe the difference between CHART-DELderived delirium diagnoses (no/yes) by age, length of stay, Charlson score
(comorbidities), and psychotropic medications duration (Table 4). The LOS differed
significantly between CHART-DEL-derived delirium diagnoses (M = 16.69) and not
having CHART-DEL-derived delirium diagnoses (M = 14.04), F (1, 172) = 5.44, p =
.021. Charlson score violated homogeneity of variance and a Kruskal-Wallis test was
used instead, resulting in a significant difference between CHART-DEL-derived delirium
diagnoses (M = 2.71) and not having CHART-DEL-derived delirium diagnoses (M =
1.92), H(1) = 4.045, p = .044. The residents with CHART-DEL-derived delirium
diagnosis had a significantly higher Charlson score (comorbidities) than those without
CHART-DEL-derived delirium diagnosis. There was no significant difference in
CHART-DEL-derived delirium diagnosis in age or psychotropic medications duration
between the two groups.
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Table 4
CHART-DEL-Derived Delirium Diagnoses by Resident Variables One-way ANOVA
Results
No
Characteristics

Yes

M

SD

M

SD

F

P

Age

80.16

8.70

82.67

7.66

2.932

.089

Length of Stay

14.04

6.64

16.69

6.34

5.440

.021

Charlson Score

1.92

1.64

2.71

2.21

6.390

.0121

8.82

8.08

11.60

8.80

3.762

.054

H

P

4.045

.044

Psychotropic Medications
Duration (days)

Nonparametric Kruskal-Wallis
Charlson Score

Note. 1Charlson Total Score violated the homogeneity of variance assumption, F(1) = 5.294, p = .023.
Therefore, the Kruskal-Wallis test was used instead.

Aims 2b. Describe the relationship between ICD-10 delirium and the variables of
gender, race, principle admitting diagnosis, polypharmacy, dementia, age, LOS, Charlson
score (comorbidities), and psychotropic medications duration.
In Table 5, all Chi-square tests run for ICD-10 Delirium violated the minimum
expected count assumption of the model and were not used in additional logistic
regression analysis for the third study aim.

66
Table 5
ICD-10 Delirium by Resident Characteristics Chi-square Results

No
Characteristics

Yes

n

%

n

%

Χ2

P

Gender (N = 174)
Female
Male

103
62

62.4
37.6

5
4

55.6
44.4

.171

.6791

Race/Ethnicity (N = 171)
White
Hispanic/Latino
Asian
Other

74
51
18
20

45.4
31.3
11.0
12.3

5
2
1
0

62.5
25.0
12.5
0.0

1.576

.6651

Polypharmacy (N = 174)
Yes
No

159
6

96.4
3.6

9
0

100.0
0.0

.339

.5601

Principle Admitting Diagnoses
(N = 174)
Infection
Major system disorder
Neurological
Cancer
Post-surgical
Musculoskeletal

34
27
20
7
44
33

20.6
16.4
12.1
4.2
26.7
20.0

2
1
1
1
2
2

22.2
11.1
11.1
11.1
22.2
22.2

1.125

.9521

ICD-10 Dementia (N = 174)
Yes
No

46
119

27.9
72.1

8
1

88.9
11.1

14.842

<.0011

Note. 1Violated the minimum expected count assumption of the model.

One-way ANOVA was used to describe the difference between ICD-10 Delirium
(no/yes) by age, length of stay, Charlson score (comorbidities), and psychotropic
medications duration (Table 6). Charlson score (comorbidities) violated homogeneity of
variance and a Kruskal-Wallis test was used instead. The Charlson score differed
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significantly between diagnosed delirium (M = 4.67) and those who were not diagnosed
with delirium (M = 1.99), H(1) = 9.935, p = .002. The residents diagnosed with delirium
had significantly higher Charlson scores (comorbidities) than those who were not
diagnosed with delirium. There was no significant difference in ICD-10 delirium in age,
length of stay or psychotropic medications duration between the two delirium groups.

Table 6
ICD-10 Delirium by Resident Characteristics One-way ANOVA Results
No
Characteristics

M

Yes

SD

M

SD

F

P

Age

80.58

8.52

85.00

7.23

2.327

.129

Length of Stay
Charlson Score
Psychotropic Medications Duration
(days)

14.80
1.99

6.62
1.66

13.33
4.67

7.37
2.83

.414
20.336

.521
<.0011

9.46

8.38

11.00

7.86

.290

.591

H

P

9.935

.002

Nonparametric Kruskal-Wallis
Charlson Score

Note. 1Charlson Total Score violated the homogeneity of variance assumption, F(1) = 6.416, p = .012.
Therefore, the Kruskal-Wallis test was used instead.

Both aim 2a and 2b results revealed significantly higher Charlson Scores
(comorbidities) for cases diagnosed with either CHART-DEL-derived delirium diagnoses
or ICD-10 delirium (p = .044 and p = .002 respectively). In contrast, only aim 2a results
revealed a significantly longer LOS for cases diagnosed with CHART-DEL-derived
delirium (p = .021).
Aim Three
Aim 3a. Determine the odds of having a CHART-DEL-derived delirium
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diagnosis based upon gender, race, principle admitting diagnosis, polypharmacy,
dementia, age, LOS, Charlson score (comorbidities), and psychotropic medications
duration.
Logistic regression was conducted to describe the effect factors may have had on
the likelihood the resident would have CHART-DEL-derived delirium diagnoses (Table
7). Both polypharmacy and race did not meet assumptions for logistic regression and
were not used. There were 174 cases with no outliers or multicollinearity. The model
contained 7 independent (factors) variables: gender, principle admitting diagnosis,
dementia, age, LOS, Charlson score (comorbidities), and psychotropic medications
duration. The overall model of 7 factors was a fairly good fit (-2 Log likelihood =
170.854) and was statistically significant, χ2(11) = 28.066, p = .003, indicating the
variable groupings, as a whole, correctly distinguishing which cases had CHART-DELderived delirium diagnoses from those that did not. The model explained 21.9%
(Nagelkerke R2) of the variance, indicating a good model fit and correctly predicted
74.1% of the cases (No = 92.2%, Yes = 22.2%). The independent variable Charlson score
significantly contributed to the model (p = 0.027). The odds ratio of 1.3 for this variable
indicated that for every one unit the Charlson score (comorbidities) increased, the odds of
having delirium determined by CHART-DEL-derived delirium diagnoses method went
up 1.3 times. Since the constant, CHART-DEL-derived delirium diagnoses, was
predicting whether or not a Yes was recorded and the coefficient was negative, then the
cases were less likely to have CHART-DEL-derived delirium diagnoses when the
independent variables were zero.
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Table 7
Logistic Regression Predicting CHART-DEL-Derived Delirium Diagnoses.
Predictor

B

SE

Wald

P

OR

CI (95%)

Age

0.05

0.03

3.64

.056

1.05

1.0, 1.10

Gender

-0.34

0.41

0.68

.409

0.72

0.32, 1.59

Charlson Score

0.26

0.12

4.90

.027

1.30

1.03, 1.63

Length of Stay

0.05

0.04

1.56

.212

1.05

0.98, 1.12

Psychotropic Medications Duration
(days)

0.03

0.03

0.99

.319

1.03

0.97, 1.09

Dementia

-0.07

0.46

0.02

.883

0.94

0.38, 2.29

Primary Diagnosis Descript Code
Infection (1)
Major system disorder (2)
Neurological (3)
Cancer (4)
Post-surgical (5)
Musculoskeletal (6)

0.68
-1.33
0.92
0.66
0.16

0.61
0.88
0.67
1.00
0.59

8.04
1.24
2.26
1.89
0.43
0.07

.154
.265
.133
.169
.510
.787

1.98
0.27
2.51
1.93
1.17

0.60, 6.53
0.05, 1.50
0.68, 9.31
0.27, 13.63
0.37, 3.72

Constant

-6.45

2.22

8.42

.004

.002

Note.CI = confidence interval for odds ratio (OR)

Aim 3b. Determine odds of having an ICD-10 derived delirium diagnosis based
upon gender, race, principle admitting diagnosis, polypharmacy, dementia, age, LOS,
Charlson score (comorbidities), and psychotropic medications duration.
Logistic regression was conducted to evaluate the effect of factors may have on
the likelihood the resident would have ICD-10 delirium (Table 8). The variables of
gender, race, principle admitting diagnosis, polypharmacy, and dementia did not meet the
assumptions for logistic regression. There were 174 cases with no outliers or
multicollinearity. The model contained 4 independent (factors) variables: age, LOS,
Charlson score (comorbidities), and psychotropic medications duration. The overall
model of 4 factors was a good fit (-2 Log likelihood = 54.082) and was statistically
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significant, χ2(4) = 16.758, p = .002, indicating the variable groupings as a whole,
correctly distinguished which cases had ICD-10 delirium from those that did not. The
model as a whole explained 27.5% (Nagelkerke R2) indicating a good model fit and
correctly predicted 94.8% of the cases (No = 89.4%, Yes = 11.1%). The independent
variable, Charlson score (comorbidities), significantly contributed to the model (p =
.001). The odds ratio of 1.63 for this variable indicated that for every one unit the
Charlson score (comorbidities) increased, the odds of having delirium determined by
ICD-10 delirium method went up 1.63 times. Since the constant, ICD-10 delirium, was
predicting whether or not a Yes was recorded and the coefficient was negative, then the
cases were less likely to have ICD-10 delirium when the independent variables were zero.

Table 8
Logistic Regression Predicting ICD-10 Delirium
Predictor

B

SE

Wald

P

OR

CI (95%)

Age

0.08

0.06

2.08

.150

1.08

0.97, 1.21

Charlson Score

0.49

0.15

10.49

.001

1.63

1.21, 2.19

Length of Stay

-0.11

0.11

1.05

.305

0.90

0.73, 1.10

Psychotropic Medications Duration
(days)

0.11

0.09

1.45

.229

1.12

0.93, 1.33

-10.57

4.92

4.61

.032

.00

Constant

Note.CI = confidence interval for odds ratio (OR)

When comparing Aim 3a and 3b results, both described a statistically significant
difference in the Charlson score (comorbidities) result (p = .027 and p = .001
respectively), indicating higher Charlson scores (comorbidities) may be a factor in the
onset of either CHART-DEL-derived delirium diagnoses or ICD-10 delirium in the LTC
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rehabilitation resident. In contrast, aim 3a results described a marginally significant
difference in age for CHART-DEL-derived delirium diagnoses (p = .056), whereas aim
3b age difference for ICD-10 delirium did not.
Summary
The information provided in this chapter were the results of the analysis of the
data. Only the Charlson score (comorbidities) variable was statistically significant in
determining the odds of having a) the symptoms of delirium determined by the CHARTDEL-derived delirium diagnoses method or b) by having an ICD-10 diagnosis of delirium
being in the medical record.
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Chapter 5
Discussion
The discussion of this study is organized into the following sections: study
findings, comparisons and contrasts to other studies, research strengths and limitations,
implications and recommendations for future practice, education, and nursing research.
Study Findings
Prior studies have identified that older adult patients were at high risk of
developing delirium when hospitalized in various healthcare settings. The relationship of
predisposing factors and precipitating factors influenced the development of the onset of
delirium. This study described the relationship of key delirium predisposing and
precipitating factors in both the CHART-DEL-derived delirium diagnosis and the ICD-10
code delirium diagnosis in the LTC rehabilitation resident.
A higher percentage of cases were White, older females, without dementia but
with polypharmacy, admitted from acute care, and discharged with home health. The
researcher identified a greater number of CHART-DEL-derived delirium diagnoses cases
(25.9%) than the ICD-10 delirium diagnosis method (5.2%). When reviewing the cases
that failed to meet the ICD-10 delirium criteria, an additional 34 cases (21.8%) met the
diagnosis criteria for CHART-DEL-derived delirium diagnoses. This may highlight not
only possible cases of unidentified delirium, but also missed opportunities for deliriumspecific treatment. The significantly longer LOS for cases diagnosed with CHART-DELderived delirium diagnoses (M= 16.69) than those without (M = 14.04) also lends
evidence to suggest that possible cases of delirium went both unidentified and untreated.
Additionally, Charlson scores were also significantly higher for identified CHART-DEL-
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derived delirium diagnoses cases (Yes; M = 2.71, No: M = 1.92) and both longer
psychotropic medications duration days (Yes: M = 11.60, No: M = 8.82) and older
residents (Yes: M = 82.67, No: M = 80.16) were marginally significant. Although the
residents, in general, were less likely to have CHART-DEL-derived delirium diagnoses,
their significant Charlson score (OR = 1.30) and marginally significant age (OR = 1.05)
helped to predict a potential diagnosis.
In comparison, the only significant factor contributing to a diagnosis of ICD-10
delirium was the Charlson score (comorbidities). Residents diagnosed with ICD-10
delirium had higher Charlson scores (comorbidities) on average (M = 4.67) than those
who were not diagnosed (M = 1.99). Likewise, although the residents, in general, were
less likely to have ICD-10 delirium, their Charlson scores (comorbidities) (OR = 1.63)
helped to predict a potential diagnosis.
The analysis results suggested a disturbing outcome regarding potential
undiagnosed and untreated delirium, which may result in longer LTC rehabilitation stays,
longer recovery times, and lower patient satisfaction, as well as increased risk of medical
complications, mortality, medical costs, and readmission rates (Huson et al., 2016;
Inouye, Westendorp, et al., 2014; Marcantonio et al., 2005). Therefore, healthcare
providers should remain attentive to potential risk factors for CHART-DEL-derived
delirium diagnoses, because timely and effective treatment could result in reduced
adverse effects and better patient outcome.

74

Figure 3. Inouye Multifactorial Model of Delirium in Older Persons (2014)

The variable of Charlson score (comorbidities), one predisposing factor out of a
total of five predisposing factors, was statistically significant in determining (using
separate models) the odds of having either a) delirium present as determined by the
CHART-DEL-derived delirium diagnoses, or b) having an ICD-10 diagnosis of delirium
in the medical record. All other predisposing and precipitating factors were not
significant study variables.
Findings Compared and Contrasted to Other Studies
Description of population
The residents in this study were older and the majority of them did not have
dementia. Age and dementia did not reach statistical significance in the current study but
had been reported as a significant risk factor for delirium in other studies. (de Lange,
Verhaak, & van der Meer, 2013; Kiely et al., 2004; Kolanowski et al., 2015; Voyer,
Richard, Doucet, & Carmichael, 2009b; Voyer et al., 2011) . One study evaluated 11
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predisposing factors finding residents over 70 with dementia were high risk factors for
the onset of delirium (Inouye, Westendorp, et al., 2014). Also, the non-cardiac surgical
population, evaluated by Inouye, Westendorp et al. (2014), were at high-risk of delirium;
however, in this study, the post-op resident did not reach statistical significance.
Dementia, age (greater than 80 years), and functional impairment were identified as
predisposing factors for delirium with dementia being the most critical factor (Voyer et
al., 2011). Another study reported that cognitive impaired participants had a higher
likelihood of developing delirium (Flanagan & Spencer, 2015).
CHART DEL-derived delirium diagnoses
In this study, the CHART-DEL instrument was used to identify delirium in the
residents of the LTC rehabilitation unit. All charts were reviewed from admission to
discharge, which included both prevalence and incidence of delirium. The overall
percentage of CHART-DEL-derived delirium diagnoses was 25.9% in this population
and not only differs from the ICD-10 coded delirium of 5.2% but also is higher than
reported in other studies. In the previous CHART-DEL validation study, the delirium
incidence was reported to be 12.5%; however, this excluded prevalence so this
percentage was not reported (Inouye et al., 2005). Another study evaluated two methods
in identifying the incidence of delirium in elective surgery hospitalized patients. The
researchers reported occurrences of delirium in both the interview-based (23%) and
CHART-DEL-derived delirium diagnoses (12%). They again excluded prevalence so
this percentage was not reported (Saczynski et al., 2014). One study evaluated the
prevalence of delirium in PAC patients using the CHART-DEL-derived delirium
diagnoses method with 9% prevalence but excluded delirium incidents (Morandi et al.,
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2009). In this study, Morandi 2009, searched keywords from “primary nurse, other
nurse, primary physician and other physician” (p. 331).
Another study utilized the Minimum Data Set (MDS) to assess prevalence of
delirium in the PAC and reported 23% delirium on admission (Marcantonio et al., 2003).
The difference between this study and some of the other previous studies may be
attributed to the fact that almost all residents in this study were admitted from acute care
at the same organization so baseline cognitive and behavioral status were obtained, which
is critical in assessing the resident for delirium. The other studies may not have access to
obtain detail knowledge of the resident’s prior healthcare visit. Another difference is the
researcher in this study included both prevalence and incidence of delirium. In other
studies the focus was to evaluate either incidence or prevalence. In this study, dementia
diagnosis was included, which could increase the risk of misclassification.
ICD-10 delirium diagnosis versus CHART-DEL-derived delirium diagnoses
Another item interest in this current study was the physician documentation of
delirium diagnosis. This was identified in 11 CHART-DEL-derived delirium cases and 9
ICD-10 cases. In the CHART-DEL instrument validation study conducted by Inouye et
al., (2005), the CHART-DEL-derived delirium diagnoses outperformed the ICD-9 coding
method with 74% and 3% respectively. The CHART-DEL instrument, which had a 3%
sensitivity, 99% specificity and 88% negative predictive accuracy (kappa = 0.03)
indicating CHART-DEL-derived delirium diagnoses, was better at excluding delirium
(Inouye et al., 2005). Another study compared the use of CAM and ICD-10
administrative databases (delirium codes entered by coder) to identify delirium incidence
in cardiac surgical patients (Katznelson et al., 2010). The study reported the hospital
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administrative database underestimated delirium incidence (Katznelson et al., 2010)
which may also reflect the difference identified between CHART-DEL-derived delirium
diagnoses and ICD-10 delirium method in this current study. Another contributing factor
was the difficulty in interpreting the handwriting. In this study, the researcher was in the
LTC rehabilitation setting when reviewing the charts and rarely consulted with the
medical record staff to help clarify a letter or word in the written documentation.
However, this may not have been the case for the coders. Other studies also reported that
the best method to identify delirium is when an interview method such as CAM is
utilized in conjunction with the CHART-DEL-derived delirium diagnoses instrument
(Inouye et al., 2005; Morandi et al., 2009; Saczynski et al., 2014).
The precipitating factors of polypharmacy and psychotropic medications duration
in this study were not factors in developing delirium as compared to previous studies.
Both polypharmacy and psychoactive medications duration were identified as
precipitating factors in the development of delirium in the medical population (Inouye,
Westendorp, et al., 2014). However, in this current study the psychotropic medications
duration did not meet significance in both the CHART-DEL-derived delirium diagnoses
and the ICD-10 delirium method. Polypharmacy in both the CHART-DEL-derived
delirium diagnoses and the ICD-10 delirium method did not meet assumptions of the test;
therefore, it was not used. In another study of an LTC population where 10 precipitating
factors evaluated the association between the development of delirium and the use of
antipsychotics was included but was not a factor (Voyer et al., 2011).
Charlson score significance - Logistic regression
In this study, the Charlson score, indicative of comorbidity, had a significant
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association when delirium was identified in both the CHART-DEL-derived delirium
diagnoses and the ICD-10 delirium method. This is consistent with previous studies
indicating that comorbidity is a high-risk predisposing factor in developing delirium. One
study stated that when there was an increase in comorbidities there was also an increase
in delirium severity (Kolanowski et al., 2014). Higher comorbidity was associated with
the development of delirium in the PAC patient population (Marcantonio et al., 2003). A
study evaluating patients recovering from a hip fracture in a rehabilitation ward reported
no significant difference in comorbidities for those patients who developed or did not
develop delirium (Heyman, Nili, Shahory, Seleznev, & Ben Natan, 2015)
LOS significance - ANOVA
In this study, length of stay (LOS) in the CHART-DEL-derived delirium
diagnoses was statistically significant versus the ICD-10 delirium method. Previous
studies supported the association of delirium and an increased LOS. Another study found
the delirious resident stayed longer in the PAC versus the resident without delirium
(Marcantonio et al., 2005). The study comparing the CAM method and the CHARTDEL-derived delirium diagnoses method to identify delirium reported a longer LOS in
both instances; 17% utilizing the CAM method and 27% utilizing the CHART-DELderived delirium diagnoses method (Saczynski et al., 2014). Another study evaluated
patients recovering from a hip fracture in a rehabilitation ward and reported no significant
difference in LOS for those patients who developed or did not develop delirium (Heyman
et al., 2015).
Strengths and Limitations
There were several strengths of this study that are worthy of being mentioned.
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The instrument, CHART-DEL, was used to identify delirium from the CHART-DELderived delirium diagnoses method review. It is a reliable and valid instrument,
(sensitivity 74%, specificity 83%, likelihood ratio 4.4, overall agreement 82% kappa =
0.41) (Inouye et al., 2005). The retrospective chart review was rigorous, extending over
the 24-hour period throughout the patients’ hospital stays and included all disciplines’
documentation: physician, nursing, physical rehabilitation therapist, occupational
rehabilitation therapist, social work, speech therapist, certified nursing assistant,
admission, discharge notes, and previous acute care discharge summary, which is
consistent with other studies. Almost all patients were from the same organization,
allowing the researcher to obtain the residents’ cognitive and behavioral baseline from
the charts and be able to evaluate changes during the entire health care encounter,
information also obtained from the charts. Lastly, review of the charts was conducted in
the facility that on rare occasion, allowed the researcher to obtain clarification of an
illegible letter or word in the documentation.
The study did have limitations that need to be acknowledged. Adjudication was
conducted by the researcher of this study and did not utilize a delirium expert panel to
reach consensus agreement. At times, illegible handwriting in the paper chart created
difficulty in interpreting the documentation and could have led to misclassification. The
CHART-DEL validation study did identify risk factors that could contribute to
misidentification of delirium including patient factors such as dementia, severity of
illness, and high baseline risk for delirium (Inouye et al., 2005). This sample included
residents with dementia that added to the complexity in identifying delirium due to the
overlapping symptoms noted between delirium and dementia (Inouye et al., 2005). The
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CHART-DEL-derived delirium diagnoses instrument does not provide the opportunity to
measure severity or type (hyperactive, hypoactive, mix) of delirium. This study was
conducted in an LTC-SNF rehabilitation unit connected to a community-based hospital,
limiting the generalizability to other PAC and stand-alone LTC rehab facilities.
Implications Practice
Identification of delirium in the LTC-SNF rehabilitation patient is critical in
reducing the risk of poor outcomes and potential sequelae (Flanagan & Spencer, 2015).
Although nurses are the primary healthcare professional on the team assessing the
patient’s mental alertness status, other disciplines may provide further assessment to help
identify delirium. Other key professionals, such as the physical therapist and
occupational therapist, assess the patient’s behavior, attention, and alertness frequently
(every other day, daily, or event twice a day) depending on the therapy order. It is
essential to ensure communication among all members of the healthcare team that may
provide early identification in the development of delirium. With early identification of
delirium, treatment can be implemented, reducing the extent of negative outcomes related
to delirium. Previous studies have reported early identification of delirium and
implementation of interventions reduced poor outcomes such as LOS and improved
cognitive and functional outcomes (Huson et al., 2016). It is important to develop the
system and structures to improve communication among all disciplines, ensuring the
physician is updated with the changes early on.
Ideally, a comprehensive delirium management program may provide a reduction
in delirium and poor outcomes associated with delirium. To develop this program would
require healthcare professionals with advanced practice skills in the geriatric population.
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Advance Practice Nurses (APNs) are masters or doctorally prepared nurses and include
Nurse Practitioner (NP) and Clinical Nurse Specialist (CNS). Both the CNS and NP can
also specialize in the care of the older adult. The CNS can provide leadership, patient
care and family education, ensure evidence-based research is the basis for clinical
practice, improve staff knowledge, and engage multidisciplinary support (Mayo et al.,
2010). The NP can provide evidence-based care, prescribing medication and treatments
(Mayo et al., 2010). Both the CNS and the NP can provide added support for the older
adult, the resident family/caregivers, and all staff caring for this population, which can
improve the resident healthcare outcomes.
This study identified that almost all patients were admitted to the LTC
rehabilitation unit from the acute care setting. Previous studies reported patients admitted
to LTC rehabilitation tended to have more acute illnesses and prevalent delirium. This
requires different clinical management than those admitted to LTC-SNF for custodial
care as these residents tend to be more frail (Marcantonio et al., 2003). Screening for
delirium is a critical practice for nurses and all disciplines. These older residents were
reported to have dementia or other cognitive impairment, which made it difficult to
identify if the patient had delirium. The use of a screening method and a reliable
instrument that generates valid data would aid in the early recognition of delirium and the
need for intervention. Additionally, the family and/or caregivers have seen their loved
one in all settings: home, acute care, long term care. This makes them a critical member
of the team, especially identifying change in cognitive status. The family member is
likely to alert the healthcare team of subtle cognitive changes indicative of early onset of
delirium that the healthcare team may not be aware of.
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The LTC rehabilitation setting does not require daily physician visits, which leads
to a decreased interaction between physicians and other members of the healthcare team
in most LTC rehabilitation settings. However, the LTC rehabilitation unit where this
study was conducted has some gerontologists who partnered with nurse practitioners to
provide care management and ongoing support to the staff. The outcome is that the
resident and staff have more interaction with the physician and/or the nurse practitioner.
This LTC rehabilitation also has a PhD-prepared nurse who provides guidance in
developing the staff and improving the LTC rehabilitation program.
The facility also has a quality control committee with members that include
bedside nurses, the medical director (gerontologist), the PhD nurse (CNS, researcher),
management, a physical therapist, a social worker, and a dietician. This team is charged
with addressing issues and making improvements in resident care and staff education.
Adding delirium as a quality measure and routinely monitoring the resident may assist in
identifying and managing delirium early on. This type of committee may be helpful in
other organizations for adaption into their particular setting.
Education
Even though the majority of residents in this study did not have dementia, one
third of the residents had dementia. The resident admitted with dementia is a challenge
for the staff as the symptoms of dementia are similar to symptoms of delirium and the
staff may not recognize the acute cognitive change. The other issue is that, in previous
studies, residents admitted from the acute care indicated a 9% or 12% prevalence of
delirium. It is essential for the staff to be knowledgeable of the two syndromes, their
symptomology, and their differences. The staff, nursing in particular, will need to be
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educated on both syndromes, the use of a screening instrument for delirium, and
immediately communicate acute changes to other members of the team. Once delirium is
identified, treatment can be implemented. Ongoing education regarding updated and
evidence-based standards and competencies for all disciplines need to be integrated into
all practice updates.
The aging population in America is growing and as a result, placing demands on
the healthcare workforce. In 2008, the Institute of Medicine (renamed the National
Academy of Medicine) not only identified the lack of geriatric content in nursing
education programs, but provided recommendations to increase formal geriatric training
to better prepare the baccalaureate and APN in ambulatory care, hospitals, and
institutional long-term care settings. The American Association of Colleges of Nursing
(AACN), National Council of State Boards of Nursing (NCSBN), and National Council
Licensure Examination (NCLEX) have worked together to ensure geriatric education,
competencies, and testing are in place to address the healthcare-related issues with the
geriatric population (IOM, 2008).
Nursing Research
Further research is needed to add to the paucity of research studies in the LTC
rehabilitation/PAC setting to address delirium. Polypharmacy and race were variables
that did not meet the assumptions of the logistic regression test for CHART-DEL-derived
delirium diagnoses. Thus, the researcher was not able to complete the evaluation of these
factors associated with onset of delirium. The categorical variables of gender, race,
principle admitting diagnosis, and dementia also did not meet the assumptions of the
logistic regression test for the ICD-10 delirium and so the researcher was not able to

84
complete the evaluation of these factors associated with onset of delirium. It is important
to test these factors in future studies, which may require a larger sample to adequately test
the factors. Replication of this study with the addition of other providers will reduce the
risk of misclassification and possibly confirm the results of this study. The ICD-10
administrative data edition was introduced in late 2015, so at the time of this study, the
method was relatively new to the coders. With time and experience, the coders are likely
to become more familiar with the ICD-10 codes and may identify delirium more often
(Quan et al., 2008). A study could be designed to determine if differences exist in
identifying delirium with the adoption of this edition. The LTC rehabilitation unit where
this study was conducted does have an MDS nurse who uses the CAM instrument to
identify delirium. The nurse performs the assessment within five days of admission and
again in 14 days or whenever the MDS nurse is notified of changes. A study to compare
the MDS-documented nurse delirium method with the CHART-DEL-derived delirium
diagnoses method could be done concurrently, daily in real time, conducted by the
bedside nurse. The ICD-10 method can then be conducted post-discharge, thus capturing
any changes during those timeframes. Lastly, it would be interesting to evaluate
assessment for delirium by all disciplines and the family and caregivers of the LTC
rehabilitation resident to determine if there might be earlier recognition of the onset of
delirium.
Conclusion
This study measured the factors associated with two different sources of the
occurrence of delirium in LTC rehabilitation unit residents, CHART-DEL-derived
delirium diagnoses and ICD-10 delirium diagnosis. Charlson score (comorbidities) was
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identified as a significant factor in the resident with delirium. In both the CHART-DELderived delirium diagnoses and ICD-10 method, the residents with higher Charlson score
(comorbidities) were 1.3 and 1.6 times, respectively, more likely to identify delirium. The
odds ratio of 1.3 (CHART-DEL-derived delirium diagnoses) and 1.63 (ICD-10 delirium
diagnosis) for these variables. This means that for every one unit the Charlson score
(comorbidities) increased, the odds of having delirium determined by CHART-DELderived delirium diagnoses method went up 1.3 times and by ICD-10 delirium method by
1.63 times
The research reported in this study provided additional and unique information to
the body of knowledge in understanding delirium in the LTC rehabilitation resident. In
this study, there was an increased number of cases identified using the CHART-DELderived delirium diagnoses method as compared to the ICD-10 method.
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